TW202102121A - Yogurt bio beverage for anti-oxidation and anti-proliferation against human digestive tract cancer cell lines, and its preparation method - Google Patents

Yogurt bio beverage for anti-oxidation and anti-proliferation against human digestive tract cancer cell lines, and its preparation method Download PDF

Info

Publication number
TW202102121A
TW202102121A TW108125099A TW108125099A TW202102121A TW 202102121 A TW202102121 A TW 202102121A TW 108125099 A TW108125099 A TW 108125099A TW 108125099 A TW108125099 A TW 108125099A TW 202102121 A TW202102121 A TW 202102121A
Authority
TW
Taiwan
Prior art keywords
yogurt
yogurt drink
extract
lactobacillus
patent application
Prior art date
Application number
TW108125099A
Other languages
Chinese (zh)
Other versions
TWI835820B (en
Inventor
錢佑
張登豪
張灝
丘錦朋
黃建誠
凃鴻宇
杜英齊
呂美津
許育銘
Original Assignee
宇洋生物醫學股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 宇洋生物醫學股份有限公司 filed Critical 宇洋生物醫學股份有限公司
Priority to TW108125099A priority Critical patent/TWI835820B/en
Publication of TW202102121A publication Critical patent/TW202102121A/en
Application granted granted Critical
Publication of TWI835820B publication Critical patent/TWI835820B/en

Links

Images

Landscapes

  • Dairy Products (AREA)

Abstract

The present invention discloses a yogurt bio beverage for anti-oxidation and anti-proliferation against human digestive tract cancer cell lines and its preparation method. The yogurt beverage includes eight to tweleve species of bacteria, which fermentate at 37℃ to 43℃ for 8 hours to 12 hours using the animal milk product. The yogurt beverage has excellent sensory evaluation, and could further contain sauces and solid (fruit) ingredients to enhance the whole sensation for eating. The yogurt beverage also is subjected to the solvents with the gradually-enhanced polarities to identify the main components therein. It is proved that the present yogurt bevenage has effects of free radical clearance, anti-oxidation, high reduction capability, and the inhibition of cancer cell growth.

Description

具抗氧化與抑制消化道癌細胞生長的優格生技飲品及其製備方法 Yogurt biotechnology drink with anti-oxidation and inhibiting growth of digestive tract cancer cells and preparation method thereof

本發明關於一種優格飲品及其製備方法。 The invention relates to a yogurt drink and a preparation method thereof.

腸-腦之間的雙向訊息網路稱為腸-腦軸(gut-brain axis),後來又發現腸道的共生菌群對此腸-腦軸具有貢獻,三者互相影響,因此成為共生菌-腸-腦軸(microbiota-gut-brain axis)。美國國家精神衛生研究院(NIMH)於2013年啟動探索腸道微生物群-大腦交流機制的特別計畫,目的為開發抗精神疾病的新藥以及非侵入性治療方法。從那時起,共生菌-腸-腦軸的相關研究如雨後春筍般展開,成為神經科學研究之焦點,主軸為探討腸道微生物群與大腦之間的相互作用。腸道微生物群透過神經網路、神經內分泌系統及免疫系統對大腦產生重要影響,而人體行為的擾動也會改變腸道微生物群的組成。文獻已報導共生菌-腸-腦軸的相互平衡關係,並證實與多種疾病相關,例如:發炎性腸道疾病(inflammatory bowel disease,IBD)、胃腸道癌症、膽石症、行為障礙、焦慮、憂鬱、慢性疲勞症候群(chronic fatigue syndrome,CFS)、肝性腦病變(hepatic encephalopathy)、過敏、肥胖、糖尿病、動脈粥樣硬化等。在癌症化療及手術後的照護上,人體臨床研究已報導藉由調控腸道微生物群的組成能改善乳癌患者的心肺健康及降低癌症復發恐懼(fear of cancer recurrence)。 The two-way information network between the gut and the brain is called the gut-brain axis. Later, it was discovered that the symbiotic flora of the intestine contributes to this gut-brain axis, and the three influence each other, so they become symbiotic bacteria. -Microbiota-gut-brain axis. The National Institutes of Mental Health (NIMH) launched a special project to explore the mechanism of intestinal microbiota-brain communication in 2013, with the purpose of developing new anti-psychiatric drugs and non-invasive treatments. Since then, related studies on the symbiotic bacteria-gut-brain axis have sprung up and become the focus of neuroscience research, with the main focus being to explore the interaction between the gut microbiota and the brain. The gut microbiota exerts an important influence on the brain through the neural network, neuroendocrine system and immune system, and the disturbance of human behavior will also change the composition of the gut microbiota. The literature has reported the mutual balance relationship between symbiotic bacteria-gut-brain axis, and confirmed that it is related to a variety of diseases, such as: inflammatory bowel disease (IBD), gastrointestinal cancer, cholelithiasis, behavior disorder, anxiety, Depression, chronic fatigue syndrome (CFS), hepatic encephalopathy (hepatic encephalopathy), allergies, obesity, diabetes, atherosclerosis, etc. In cancer chemotherapy and post-surgery care, human clinical studies have reported that regulating the composition of the intestinal microbiota can improve the cardiopulmonary health of breast cancer patients and reduce the fear of cancer recurrence.

目前,西醫及中醫體系正積極發展、或結合共生菌-腸-腦軸 的研究進行藥物開發、疾病治療及其作用機轉的研究;而另一醫療系統-阿育吠陀(Ayurveda)使用大量薑黃於改善消化道不適、神經保護、預防阿茲海默症,其多樣性的功效也與腸-腦軸有相關。但由於飲食習慣不同,薑黃的使用有區域性的限制,主要在印度。 At present, Western medicine and Chinese medicine systems are actively developing, or combining symbiotic bacteria-gut-brain axis Research on drug development, disease treatment and its mechanism of action; and another medical system, Ayurveda, uses a large amount of turmeric to improve digestive tract discomfort, neuroprotection, and prevent Alzheimer’s disease. Its diversity The efficacy of the intestine-brain axis is also related. However, due to different dietary habits, the use of turmeric has regional restrictions, mainly in India.

在西醫體系中,利用共生菌-腸-腦軸研究進行藥物開發稱之為微生態藥物,其係指利用正常微生物或調節微生物正常生長的物質所製成的藥物製劑。可應用於感染、糖尿病、腫瘤、發炎疾病、免疫相關疾病等適應症。微生態藥物包括:活體生物藥(live biotherapeutic product,LBP)、小分子微生態調節劑(small molecule microbiome modulator,SMMM)、糞菌移植(fecal microbiota transplant,FMT)。其中,LBP係指透過對人體微生物的鑑定、篩選及組合而明確控制菌體種類及數量,針對不同適應症採用不同菌體種類、數量及其組合來確保用藥的安全性及有效性。然而,美國食品藥物管理局(FDA)至今尚未批准任何LBP上市,只在2016年發佈LBP的早期臨床試驗指南,使得LBP的開發具有明確標準。SMMM係指能夠選擇性促進宿主腸道的一或多種有益細菌生長繁殖的物質,藉由影響菌體的生長繁殖達成治療目的。目前已知的SMMM藥物開發只到臨床二期。FMT則是指將健康人體糞便的功能菌群移植至患者胃腸道,重建患者的腸道菌群,以進行腸道及腸道外疾病的治療。雖然美國已於2013年將FMT列入復發性困難梭狀桿菌感染(Clostridium difficile infection)的治療指南,但不同國家的政策差異大,FMT目前缺乏統一及有效的監管。整體而言,微生態藥物的臨床試驗進展不如預期,目前尚無批准上市的微生態藥物。另一問題是微生態藥物的臨床試驗人數相對較少,藥物療效的人體驗證仍不如預期。 In the Western medical system, the use of symbiotic bacteria-gut-brain axis research for drug development is called microecological drugs, which refers to pharmaceutical preparations made from normal microorganisms or substances that regulate the normal growth of microorganisms. It can be applied to indications such as infection, diabetes, tumor, inflammatory disease, immune-related disease, etc. Microecological drugs include: live biotherapeutic product (LBP), small molecule microbiome modulator (SMMM), and fecal microbiota transplant (FMT). Among them, LBP refers to the clear control of the types and numbers of bacteria through the identification, screening and combination of human microorganisms, and the use of different types, numbers and combinations of bacteria for different indications to ensure the safety and effectiveness of the medication. However, the U.S. Food and Drug Administration (FDA) has not yet approved any LBP listing, and only released early clinical trial guidelines for LBP in 2016, making the development of LBP have clear standards. SMMM refers to a substance that can selectively promote the growth and reproduction of one or more beneficial bacteria in the host's intestines, and achieve the purpose of treatment by affecting the growth and reproduction of bacteria. The current known SMMM drug development has only reached the second clinical stage. FMT refers to transplanting the functional flora of healthy human feces to the patient's gastrointestinal tract to rebuild the patient's intestinal flora for the treatment of intestinal and extra-intestinal diseases. Although the United States has included FMT in the treatment guidelines for recurrent Clostridium difficile infection in 2013, the policies of different countries are very different, and FMT currently lacks unified and effective supervision. On the whole, the progress of clinical trials of microecological drugs has not been as expected, and there are currently no microecological drugs approved for marketing. Another problem is that the number of clinical trials of microecological drugs is relatively small, and the human verification of drug efficacy is still not as expected.

中醫體系並非利用共生菌-腸-腦軸研究開發藥物,而是研究中藥與腸道微生物群的相互作用。中藥對於腸道微生物群的調節作用例如:含有多醣的補益類中藥對於益菌及病原菌具有扶植作用,但對於益菌 的扶植效果明顯優於病原菌,而生長良好的益菌所產生的代謝物又間接抑制病原菌生長。例如,黨參多醣在體外可促進雙歧桿菌生長,進而增加乙酸代謝,增強雙歧桿菌的定殖抗性(colonization resistance)。腸道微生物群對於中藥的代謝作用例如:目前已證實許多中藥成分只有經過腸道微生物群的代謝才產生藥效成分而達到治療效果。例如,黃芩所含的黃芩苷(baicalin)在腸道內難以被直接吸收,只有被腸道微生物群水解為黃芩素(baicalein)才能被吸收進入血液而發揮作用。人體臨床試驗證實,葛根芩連湯可藉由改變腸道微生物群治療第二型糖尿病。整體而言,共生菌-腸-腦軸的中藥研究提供了西方醫學可接受的作用機轉解釋,但仍無法改善中藥因劑量太高、治療時間太長而導致服藥順從性(drug compliance)及服藥依順性(medication adherence)皆低的老問題。 The Chinese medicine system does not use symbiotic bacteria-gut-brain axis to research and develop drugs, but to study the interaction between Chinese medicine and gut microbiota. The regulating effect of traditional Chinese medicine on the intestinal microbiota. For example, tonic traditional Chinese medicine containing polysaccharides can support beneficial bacteria and pathogenic bacteria, but for beneficial bacteria The planting effect is significantly better than that of pathogenic bacteria, and the metabolites produced by well-growing beneficial bacteria indirectly inhibit the growth of pathogenic bacteria. For example, Codonopsis pilosula polysaccharide can promote the growth of bifidobacteria in vitro, thereby increasing acetic acid metabolism and enhancing the colonization resistance of bifidobacteria. The metabolic effects of the gut microbiota on traditional Chinese medicine. For example, it has been confirmed that many traditional Chinese medicine components can only produce medicinal ingredients through the metabolism of the gut microbiota to achieve therapeutic effects. For example, baicalin contained in Scutellaria baicalensis is difficult to be directly absorbed in the intestinal tract. Only when it is hydrolyzed by the intestinal microbiota into baicalein can it be absorbed into the blood and play a role. Human clinical trials have confirmed that Gegen Qinlian Decoction can treat type 2 diabetes by changing the intestinal microbiota. On the whole, the study of symbiotic bacteria-gut-brain axis of traditional Chinese medicine provides an explanation of the mechanism acceptable to western medicine, but it still fails to improve the drug compliance and drug compliance caused by the high dose and long treatment time of traditional Chinese medicine. The old problem of low medication adherence.

上述西醫、中醫及阿育吠陀醫療系統對於共生菌-腸-腦軸的研究與開發著重在疾病、藥物及治療。整體而言,這些發展仍處於萌芽期,尚未具有產業上成功案例或具規模的量產。因此,仍須開發新穎可應用於共生菌-腸-腦軸的產品及技術,以達生物醫學的功效。 The research and development of the above-mentioned western medicine, traditional Chinese medicine and Ayurvedic medical system for the symbiotic bacteria-gut-brain axis focuses on diseases, medicines and treatments. On the whole, these developments are still in their infancy, and there are no successful industrial cases or large-scale mass production. Therefore, it is still necessary to develop novel products and technologies that can be applied to the symbiotic bacteria-gut-brain axis to achieve biomedical effects.

本案申請人鑑於習知技術中的不足,經過悉心試驗與研究,並一本鍥而不捨的精神,終構思出本案,能夠克服先前技術的不足,以下為本案的簡要說明。 In view of the shortcomings of the prior art, the applicant in this case, after careful experimentation and research, and with a spirit of perseverance, finally conceived this case, which can overcome the shortcomings of the previous technology. The following is a brief description of the case.

本發明之目的為提供一種優格飲品,包括:動物乳汁製品及複數菌粉,動物乳汁製品包括水及動物乳汁,複數菌粉與動物乳汁製品相混合,其中複數菌粉來自於對應的複數種菌株,複數種菌株包括:長雙岐桿菌(Bifidobacterium longum)、嗜酸乳桿菌(Lactobacillus acidophilus)、副乾酪乳桿菌(Lactobacillus paracasei)以及鼠李糖桿菌(Lactobacillus rhamnosus)。 The purpose of the present invention is to provide a yogurt drink, including: animal milk products and plural bacteria powder, animal milk products including water and animal milk, plural bacteria powder and animal milk products are mixed, wherein the plural bacteria powder comes from the corresponding plural species Strains, plural strains include: Bifidobacterium longum (Bifidobacterium longum), Lactobacillus acidophilus (Lactobacillus acidophilus), Lactobacillus paracasei (Lactobacillus paracasei) and Rhamnosus ( Lactobacillus rhamnosus ).

前述優格飲品更包括由下列菌株所組成的群組:比菲德氏菌(Bifidobacterium bifidum)、短雙岐桿菌(Bifidobacterium breve)、嬰兒雙岐桿菌(Bifidobacterium infantis)、雷特氏雙岐桿菌(Bifidobacterium lactis)、糞腸球菌(Enterococcus faecium)、乾酪乳桿菌(Lactobacillus casei)、保加利亞乳桿菌(Lactobacillus delbrueckii subsp.bulgaricus)、發酵乳桿菌(Lactobacillus fermentum)、瑞士乳桿菌(Lactobacillus helveticus)、植物乳桿菌(Lactobacillus plantarum)、唾液乳酸桿菌(Lactobacillus salivarius)以及嗜熱鏈球菌(Streptococcus thermophilus)。 The aforementioned yogurt drink further includes a group consisting of the following strains: Bifidobacterium bifidum , Bifidobacterium breve , Bifidobacterium infantis , and Bifidobacterium breve. Bifidobacterium lactis , Enterococcus faecium , Lactobacillus casei , Lactobacillus delbrueckii subsp. bulgaricus , Lactobacillus fermentum , Lactobacillus fermentum, Lactobacillus helveticus , Lactobacillus helveticus ( Lactobacillus plantarum ), Lactobacillus salivarius (Lactobacillus salivarius ), and Streptococcus thermophilus (Streptococcus thermophilus ).

本發明之另一目的為提供一種前述優格飲品的分離方法,包括:冷凍乾燥該優格飲品,獲得粉狀產物;以正己烷萃取粉狀產物,獲得正己烷萃取物及第一殘留物,其中正己烷萃取物的主量成分為具有雙鍵及氫氧基的短鏈脂肪酸;以乙酸乙酯萃取第一殘留物,獲得乙酸乙酯萃取物及第二殘留物,其中乙酸乙酯萃取物的主量成分為糖脂;以乙醇萃取第二殘留物,獲得乙醇萃取物及第三殘留物,其中乙醇萃取物的主量成分包括雙醣及寡醣;以及以水萃取第三殘留物,獲得水萃取物及第四殘留物,其中水萃取物的主量成分包括多醣、醣蛋白以及蛋白質。 Another object of the present invention is to provide a method for separating the aforementioned yogurt drink, comprising: freeze-drying the yogurt drink to obtain a powdered product; extracting the powdered product with n-hexane to obtain a n-hexane extract and a first residue, The main component of the n-hexane extract is short-chain fatty acids with double bonds and hydroxyl groups; the first residue is extracted with ethyl acetate to obtain an ethyl acetate extract and a second residue, wherein the ethyl acetate extract The main component is glycolipid; the second residue is extracted with ethanol to obtain an ethanol extract and a third residue, where the main components of the ethanol extract include disaccharides and oligosaccharides; and the third residue is extracted with water, A water extract and a fourth residue are obtained, wherein the main components of the water extract include polysaccharides, glycoproteins and proteins.

本發明的另一目的為提供一種將前述優格飲品用於抑制癌細胞生長的用途,其中癌細胞選自由血癌細胞、腦癌細胞、胃癌細胞、大腸癌細胞及/或其組合。 Another object of the present invention is to provide a use of the aforementioned yogurt drink for inhibiting the growth of cancer cells, wherein the cancer cells are selected from blood cancer cells, brain cancer cells, gastric cancer cells, colorectal cancer cells, and/or combinations thereof.

本發明揭露一種用於製備優格飲品的發酵機,包括:槽體、密封頂蓋。密封頂蓋與槽體組裝,使密封頂蓋與槽體所圍設的一空間為密閉。投料口設置於密封頂蓋上,水、奶粉以及菌粉經由投料口被送入該空間。電機控制器設置於槽體外,攪拌馬達耦接於電機控制器,攪拌臂設置於該空間內且連接於攪拌馬達,用以攪拌水、奶粉以及菌粉。電阻增溫器 設置於槽體外且耦接於電機控制器,用以消毒水及奶粉,並使菌粉在水以及奶粉所形成的混合物中於37℃至43℃之間進行發酵,製備成該優格飲品。 The invention discloses a fermentation machine for preparing yogurt drinks, which comprises a tank body and a sealing top cover. The sealing top cover is assembled with the tank body, so that a space enclosed by the sealing top cover and the tank body is sealed. The feeding port is arranged on the sealed top cover, and water, milk powder and bacterial powder are fed into the space through the feeding port. The motor controller is arranged outside the tank, the stirring motor is coupled to the motor controller, and the stirring arm is arranged in the space and connected to the stirring motor for stirring water, milk powder and bacterial powder. Resistance warmer It is arranged outside the tank and coupled to the motor controller for disinfecting water and milk powder, and fermenting the bacterial powder in the mixture formed by the water and milk powder at 37°C to 43°C to prepare the yogurt drink.

在本發明中,發酵機還包括槽體底部的出料口,優格飲品由出料口送出。槽體外的控溫夾層,與電阻增溫器連接,控溫夾層受電阻增溫器的控制而調整或維持該空間的溫度。密封頂蓋上還包括清洗口,槽體側邊包括導熱流入口,槽體底部包括導熱流出口。 In the present invention, the fermentation machine further includes a discharge port at the bottom of the tank, and the yogurt drink is sent out from the discharge port. The temperature control interlayer outside the tank is connected with the resistance warmer, and the temperature control interlayer is controlled by the resistance warmer to adjust or maintain the temperature of the space. The sealing top cover also includes a cleaning port, the side of the tank body includes a heat conduction inflow port, and the bottom of the tank body includes a heat conduction outflow port.

在本發明中,發酵機還包括耦接於電機控制器的感溫探測器,電機控制器還包括一螢幕,感溫探測器感測的溫度顯示在螢幕上。密封頂蓋還包括觀察窗,用以供使用者目視槽體內的狀況。 In the present invention, the fermentation machine further includes a temperature sensor coupled to the motor controller, and the motor controller further includes a screen, and the temperature sensed by the temperature sensor is displayed on the screen. The sealing top cover also includes an observation window for the user to visually observe the condition in the tank.

本文用語「動物乳汁製品」大體上包括水及動物乳汁,動物乳汁可以液態形式存在,或是經巴斯德滅菌法而乾燥為粉末形式,且動物乳汁的來源可為人乳、牛乳或羊奶等。 The term "animal milk products" as used herein generally includes water and animal milk. Animal milk can exist in liquid form, or pasteurized and dried into powder form, and the source of animal milk can be human milk, cow milk or goat milk Wait.

本文的各種細菌菌株及癌症細胞株均可透過市售方式取得,並無須進行生物材料寄存。本文的優格飲品在冷藏及室溫環境下為液態。本文優格飲品中的菌株在37℃至43℃的溫度及8小時至12小時的發酵時間呈現不等的發酵結果。 The various bacterial strains and cancer cell strains in this article can be obtained through commercial methods, and there is no need to deposit biological materials. The yogurt drink in this article is liquid under refrigeration and room temperature. The strains in the yogurt drink in this article showed varying fermentation results at a temperature of 37°C to 43°C and a fermentation time of 8 hours to 12 hours.

3‧‧‧分離方法 3‧‧‧Separation method

12‧‧‧優格飲品原液 12‧‧‧ Yogurt drink stock solution

14‧‧‧粉狀產物 14‧‧‧Powdered product

16‧‧‧正己烷萃取物 16‧‧‧N-hexane extract

18‧‧‧第一殘留物 18‧‧‧First residue

20‧‧‧乙酸乙酯萃取物 20‧‧‧Ethyl acetate extract

22‧‧‧第二殘留物 22‧‧‧Second residue

24‧‧‧乙醇萃取物 24‧‧‧Ethanol extract

26‧‧‧第三殘留物 26‧‧‧Third residue

28‧‧‧水萃取物 28‧‧‧Water extract

30‧‧‧第四殘留物 30‧‧‧The fourth residue

100‧‧‧發酵機 100‧‧‧Fermenting machine

101‧‧‧槽體 101‧‧‧Slot body

102‧‧‧控溫夾層 102‧‧‧Temperature control sandwich

103‧‧‧電阻增溫器 103‧‧‧Resistance Warmer

104‧‧‧攪拌臂 104‧‧‧Stirring arm

105‧‧‧密封頂蓋 105‧‧‧Sealed top cover

106‧‧‧清洗口 106‧‧‧Cleaning port

107‧‧‧感溫探測器 107‧‧‧Temperature detector

108‧‧‧電機控制器 108‧‧‧Motor Controller

109‧‧‧螢幕 109‧‧‧Screen

110‧‧‧攪拌馬達 110‧‧‧Stirring motor

M‧‧‧投料口 M‧‧‧Feeding port

N4‧‧‧出料口 N4‧‧‧Discharge port

N5‧‧‧導熱流入口 N5‧‧‧Heat conduction inlet

N6‧‧‧導熱流出口 N6‧‧‧Heat conduction outlet

S1‧‧‧觀察窗 S1‧‧‧Observation window

第1圖為菌種代號LR-36的16S rDNA定序結果及NCBI比對結果,為鼠李糖桿菌(Lactobacillus rhamnosus)。 Figure 1 shows the 16S rDNA sequencing results of the strain code LR-36 and the NCBI comparison results. It is Lactobacillus rhamnosus (Lactobacillus rhamnosus).

第2圖為菌種代號LPL-68的16S rDNA定序結果及NCBI比對結果,為植物乳桿菌(Lactobacillus plantarum)。 Figure 2 shows the 16S rDNA sequencing results and NCBI comparison results of the strain code LPL-68, which is Lactobacillus plantarum .

第3圖(A)為菌種代號UY-58的顯微照片。為革蘭氏陽性桿菌,不具觸酶、氧化酶及運動性,不會產生內生孢子,於好氧及厭氧環境下皆會生長。 Figure 3 (A) is a photomicrograph of the strain code UY-58. It is a gram-positive bacillus, has no catalase, oxidase and motility, does not produce endospores, and can grow in both aerobic and anaerobic environments.

第3圖(B)為菌種代號UY-58的16S rDNA定序結果。最接近發酵乳桿菌(Lactobacillus fermentum),相似性為99.9%。 Figure 3 (B) shows the 16S rDNA sequencing result of the strain code UY-58. Closest to Lactobacillus fermentum (Lactobacillus fermentum), the similarity is 99.9%.

第4圖(A)為菌種代號UY-76的顯微照片。為革蘭氏陽性桿菌,不具觸酶、氧化酶及運動性,不會產生內生孢子,於好氧及厭氧環境下皆會生長。 Figure 4 (A) is a photomicrograph of the strain code UY-76. It is a gram-positive bacillus, has no catalase, oxidase and motility, does not produce endospores, and can grow in both aerobic and anaerobic environments.

第4圖(B)為菌種代號UY-76的16S rDNA定序結果。最接近瑞士乳桿菌(Lactobacillus helveticus),相似性為100%。 Figure 4 (B) shows the 16S rDNA sequencing result of the strain code UY-76. Closest to Lactobacillus helveticus (Lactobacillus helveticus), the similarity is 100%.

第5圖為分離方法3的流程圖。 Figure 5 is a flowchart of separation method 3.

第6圖(A)為優格飲品11正己烷萃取物(11-H)的1H-NMR圖譜。 Figure 6 (A) shows the 1 H-NMR spectrum of the 11-hexane extract (11-H) of Yogurt Drink.

第6圖(B)為優格飲品11乙酸乙酯萃取物(11-E)的1H-NMR圖譜。 Figure 6 (B) shows the 1 H-NMR spectrum of the 11 ethyl acetate extract (11-E) of Yogurt Drink.

第6圖(C)為優格飲品11乙醇萃取物(11-A)的1H-NMR圖譜。 Figure 6 (C) shows the 1 H-NMR spectrum of the 11 ethanol extract (11-A) of Yogurt Drink.

第6圖(D)為優格飲品11水萃取物(11-W)的1H-NMR圖譜。 Figure 6 (D) is the 1 H-NMR spectrum of the 11 water extract (11-W) of Yogurt Drink.

第7圖(A)為優格飲品12正己烷萃取物(12-H)的1H-NMR圖譜。 Figure 7 (A) shows the 1 H-NMR spectrum of the 12-hexane extract (12-H) of Yogurt Drink.

第7圖(B)為優格飲品12乙酸乙酯萃取物(12-E)的1H-NMR圖譜。 Figure 7 (B) is the 1 H-NMR spectrum of the 12 ethyl acetate extract (12-E) of Yogurt Drink.

第7圖(C)為優格飲品12乙醇萃取物(12-A)的1H-NMR圖譜。 Figure 7 (C) shows the 1 H-NMR spectrum of the 12 ethanol extract (12-A) of Yogurt Drink.

第7圖(D)為優格飲品12水萃取物(12-W)的1H-NMR圖譜。 Figure 7 (D) shows the 1 H-NMR spectrum of the 12-water extract (12-W) of Yogurt Drink.

第8圖(A)為優格飲品13正己烷萃取物(13-H)的1H-NMR圖譜。 Figure 8 (A) shows the 1 H-NMR spectrum of the 13-hexane extract (13-H) of Yogurt Drink.

第8圖(B)為優格飲品13乙酸乙酯萃取物(13-E)的1H-NMR圖譜。 Figure 8 (B) shows the 1 H-NMR spectrum of the 13 ethyl acetate extract (13-E) of Yogurt Drink.

第8圖(C)為優格飲品13乙醇萃取物(13-A)的1H-NMR圖譜。 Figure 8 (C) shows the 1 H-NMR spectrum of the 13 ethanol extract (13-A) of Yogurt Drink.

第8圖(D)為優格飲品13水萃取物(13-W)的1H-NMR圖譜。 Figure 8 (D) is the 1 H-NMR spectrum of the 13 water extract (13-W) of Yogurt Drink.

第9圖(A)為優格飲品14正己烷萃取物(14-H)的1H-NMR圖譜。 Figure 9 (A) is the 1 H-NMR spectrum of the 14-H hexane extract (14-H) of Yogurt Drink.

第9圖(B)為優格飲品14乙酸乙酯萃取物(14-E)的1H-NMR圖譜。 Figure 9 (B) shows the 1 H-NMR spectrum of the 14 ethyl acetate extract (14-E) of Yogurt Drink.

第9圖(C)為優格飲品14乙醇萃取物(14-A)的1H-NMR圖譜。 Figure 9 (C) shows the 1 H-NMR spectrum of the ethanol extract of Yogurt Drink 14 (14-A).

第9圖(D)為優格飲品14水萃取物(14-W)的1H-NMR圖譜。 Figure 9 (D) shows the 1 H-NMR spectrum of the 14 water extract (14-W) of Yogurt Drink.

第10圖為優格飲品11至14經分離方法3所獲得各萃取物的總多酚含量分析柱狀圖。 Figure 10 is a bar graph of the total polyphenol content analysis of each extract obtained by separation method 3 of Yogurt Drinks 11-14.

第11圖為優格飲品11至14經分離方法3所獲得各萃取物的總 flavanone類黃酮含量分析柱狀圖。 Figure 11 shows the total of each extract obtained by separation method 3 of Yogurt Drinks 11-14 Flavanone flavonoid content analysis histogram.

第12圖為優格飲品11至14經分離方法3所獲得各萃取物的總多醣含量分析柱狀圖。 Figure 12 is a histogram of total polysaccharide content analysis of each extract obtained by separation method 3 of Yogurt Drinks 11-14.

第13圖為優格飲品11經分離方法3所獲得各萃取物在203nm波長的HPLC圖譜。 Figure 13 shows the HPLC spectrum of each extract obtained by separation method 3 of Yogurt Drink 11 at a wavelength of 203 nm.

第14圖為優格飲品12經分離方法3所獲得各萃取物在203nm波長的HPLC圖譜。 Figure 14 shows the HPLC spectrum of each extract obtained by separation method 3 of Yogurt Drink 12 at a wavelength of 203 nm.

第15圖為優格飲品13經分離方法3所獲得各萃取物在203nm波長的HPLC圖譜。 Figure 15 shows the HPLC spectrum of each extract obtained by separation method 3 of Yogurt Drink 13 at a wavelength of 203 nm.

第16圖為優格飲品14經分離方法3所獲得各萃取物在203nm波長的HPLC圖譜。 Figure 16 shows the HPLC spectrum of each extract obtained by separation method 3 of Yogurt Drink 14 at a wavelength of 203 nm.

第17圖為優格飲品11至14經分離方法3所獲得各萃取物的DPPH自由基清除率柱狀圖。 Figure 17 is a bar graph of the DPPH free radical scavenging rate of each extract obtained from Yogurt Drinks 11 to 14 through separation method 3.

第18圖為優格飲品11至14經分離方法3所獲得各萃取物的總抗氧化能力-ABTS自由基清除率柱狀圖。 Figure 18 is a histogram of the total antioxidant capacity-ABTS free radical scavenging rate of each extract obtained by the separation method 3 of Yogurt Drinks 11-14.

第19圖為優格飲品11至14經分離方法3所獲得各萃取物的還原力測定柱狀圖。 Figure 19 is a bar graph of the reducing power of each extract obtained by separation method 3 of yogurt drinks 11-14.

第20圖為優格飲品11至14經分離方法3所獲得各萃取物的血癌細胞存活抑制率柱狀圖。 Figure 20 is a histogram of the survival inhibition rate of blood cancer cells of each extract obtained from Yogurt Drinks 11 to 14 by separation method 3.

第21圖為優格飲品11至14經分離方法3所獲得各萃取物的腦癌細胞存活抑制率柱狀圖。 Figure 21 is a histogram of the survival inhibition rate of brain cancer cells of each extract obtained from Yogurt Drink 11 to 14 through separation method 3.

第22圖為優格飲品11至14經分離方法3所獲得各萃取物的胃癌細胞存活抑制率柱狀圖。 Figure 22 is a histogram of the survival inhibition rate of gastric cancer cells of each extract obtained from Yogurt Drinks 11 to 14 through separation method 3.

第23圖為優格飲品11至14經分離方法3所獲得各萃取物的大腸癌細胞存活抑制率柱狀圖。 Figure 23 is a histogram of the survival inhibition rate of colorectal cancer cells of each extract obtained from Yogurt Drink 11 to 14 through separation method 3.

第24圖為優格飲品11至14經分離方法3所獲得各萃取物的前列腺癌 細胞存活抑制率柱狀圖。 Figure 24 shows the prostate cancer of each extract obtained by separation method 3 of Yogurt Drinks 11 to 14 Histogram of cell survival inhibition rate.

第25圖為優格飲品生產系統流程圖。 Figure 25 is the flow chart of the Yogurt beverage production system.

第26圖為優格飲品發酵機圖。 Picture 26 shows the yogurt beverage fermentation machine.

本發明的上述目的及優點在參閱以下詳細說明及附圖之後對那些所屬技術領域中具有通常知識者將變得更立即地顯而易見。 The above-mentioned objects and advantages of the present invention will become more immediately apparent to those with ordinary knowledge in the technical field after referring to the following detailed description and drawings.

本發明將優格的活性代謝物進行活性導引分離,確定活性成分並調製成適合口服的飲品或藥劑,且仍保持成分的功效。 In the present invention, the active metabolites of yogurt are separated by active guidance, the active ingredients are determined and prepared into drinks or medicaments suitable for oral administration, and the efficacy of the ingredients is still maintained.

實驗1、菌種的分離與鑑定:Experiment 1. Isolation and identification of strains:

取1ml的生牛乳作為樣品,以乳酸桿菌MRS培養基(Lactobacilli MRS Broth)作為稀釋液進行10倍連續稀釋(濃度倍數分別為10-1、10-2、10-3、10-4),分別取200μl稀釋物滴於無菌MRS洋菜培養基,再進行塗盤。將培養皿置於37℃厭氧培養箱培養24小時。之後無菌挑選型態、顏色、大小不同的單一菌落繼續培養,並反覆挑選菌落及培養以分離菌種,確定培養皿上的菌落皆為相同形態、顏色、大小。最後將分離的單一菌株進行菌種保存及鑑定。優格菌種的鑑定係先以肉眼觀察培養皿上為單一菌落,再挑選二個相同菌落進行格蘭氏染色,確定為格蘭氏陽性或陰性菌。較佳地是以相位差顯微鏡於4及40倍倍數下觀察菌落。挑選單一菌落進行DNA萃取及16S PCR試驗,以NCBI資料庫比對序列,由其結果完成鑑定。 Take 1ml of raw cow's milk as a sample, and use Lactobacilli MRS Broth as a diluent to perform 10-fold serial dilutions (concentration multiples of 10 -1 , 10 -2 , 10 -3 , and 10 -4 ), and take them separately 200μl of the dilution was dropped into sterile MRS agar culture medium, and then plated. Place the petri dish in an anaerobic incubator at 37°C for 24 hours. After that, single colonies of different types, colors, and sizes are aseptically selected and continued to be cultured, and the colonies are selected and cultured repeatedly to isolate the bacteria, and it is determined that the colonies on the petri dish have the same shape, color, and size. Finally, the isolated single strain is preserved and identified. The identification of the yogurt strain is to observe the single colony on the petri dish with the naked eye, and then select two identical colonies for Gram staining to determine the Gram-positive or negative bacteria. Preferably, the colony is observed by a phase-contrast microscope at 4 and 40 times magnification. Select a single colony for DNA extraction and 16S PCR test, compare the sequence with the NCBI database, and complete the identification based on the result.

如第1及2圖所示,菌種代號LR-36以及LPL-68經16S rDNA定序及NCBI比對後,其分別為鼠李糖桿菌(Lactobacillus rhamnosus)以及植物乳桿菌(Lactobacillus plantarum)。此外,如第3圖(A)、第3圖(B)及表1所示,菌種代號UY-58經顯微鏡觀察鑑定、DNA萃取、16S rDNA定序(SEQ ID NO:1)、API 50 CHL鑑定,確認為革蘭氏陽性菌,且最接近 發酵乳桿菌(Lactobacillus fermentum,相似性為99.9%)。第4圖(A)及第4圖(B)為菌種代號UY-76經顯微鏡觀察鑑定、DNA萃取、16S rDNA定序(SEQ ID NO:2)、API 50 CHL鑑定,確認為革蘭氏陽性桿菌,且最接近瑞士乳桿菌(Lactobacillus helveticus,相似性為100%)。 As shown in Figures 1 and 2, after 16S rDNA sequencing and NCBI alignment, the strain codes LR-36 and LPL-68 are Lactobacillus rhamnosus and Lactobacillus plantarum , respectively. In addition, as shown in Figure 3 (A), Figure 3 (B) and Table 1, the strain code UY-58 was identified by microscope observation, DNA extraction, 16S rDNA sequencing (SEQ ID NO:1), API 50 CHL identification confirmed that it is a gram-positive bacteria, and the closest to Lactobacillus fermentum (Lactobacillus fermentum, similarity is 99.9%). Figure 4 (A) and Figure 4 (B) show that the strain code UY-76 was identified by microscope observation, DNA extraction, 16S rDNA sequencing (SEQ ID NO: 2), API 50 CHL identification, and confirmed to be Gram Positive bacilli, and closest to Lactobacillus helveticus (Lactobacillus helveticus, 100% similarity).

Figure 108125099-A0101-12-0009-92
Figure 108125099-A0101-12-0009-92
Figure 108125099-A0101-12-0010-93
Figure 108125099-A0101-12-0010-93

Figure 108125099-A0101-12-0010-94
Figure 108125099-A0101-12-0010-94

經過分離、鑑定,共取得20株菌種,依拉丁文名稱順序排列如表3所示。 After isolation and identification, a total of 20 strains were obtained, which are arranged in the order of Latin names as shown in Table 3.

Figure 108125099-A0101-12-0011-95
Figure 108125099-A0101-12-0011-95

實驗2、優格的發酵製備:Experiment 2. Fermentation preparation of yogurt:

本發明發酵製備實驗的設計模型是以菌種種類及比例、發酵溫度、及發酵時間為操縱變因,發酵後以黏度、酸鹼值(pH)為品管標準。優格黏度在100釐泊(cP)以下、pH值5.0以上判定為未發酵或發酵不完 全,發酵時間過長(超過12小時)的實驗組因考量生產效率不佳也被淘汰。實驗2的製備方法為:將250ml之75℃熱水加入36g奶粉進行高溫殺菌,成為動物乳汁製品。待其冷卻至35~43℃,加入0.3g菌粉。再分別置於不同溫度(37℃、40℃、43℃)培養箱反應不同時間(8小時、10小時、12小時),之後測量黏度(Brookfield DVE RV黏度計)與pH值(Milwaukee pH600酸鹼度計)。表4為14組成功發酵的菌種組合所含之菌株。 The design model of the fermentation preparation experiment of the present invention is based on the type and ratio of strains, fermentation temperature, and fermentation time as operating variables, and viscosity and pH value (pH) are used as quality control standards after fermentation. Yogurt with a viscosity below 100 centipoise (cP) and a pH value above 5.0 is judged as unfermented or incompletely fermented In general, the experimental group with too long fermentation time (more than 12 hours) was also eliminated due to poor production efficiency. The preparation method of experiment 2 is: adding 250 ml of hot water at 75° C. into 36 g of milk powder for high-temperature sterilization to become an animal milk product. When it is cooled to 35~43℃, add 0.3g of bacterial powder. Then put in different temperature (37℃, 40℃, 43℃) incubator and react for different time (8 hours, 10 hours, 12 hours), and then measure the viscosity (Brookfield DVE RV viscometer) and pH value (Milwaukee pH600 pH meter) ). Table 4 shows the strains contained in the 14 groups of successfully fermented strain combinations.

Figure 108125099-A0101-12-0012-96
Figure 108125099-A0101-12-0012-96

結果發現,不同奶粉對於是否能成功發酵的影響不大;菌種種類之間的重量比例對於發酵結果影響亦不大。因此,各實驗組別菌種種類之間的(菌粉)重量比例皆為1:1,而菌種種類越多表明具有越容易成功發酵的趨勢,亦即菌種種類越多,成功發酵的實驗再現性越高。接著,以 成功發酵再現性最高的4組(表4的菌種組合11至14)進行3重複實驗,確認不同菌種組合的最佳發酵條件(即,能在最短發酵時間內達到最高黏度與最低pH值),優格黏度高於100cp、pH值低於5.0時,判定為發酵完全。實驗結果如表5所示。 It was found that different milk powders had little effect on the success of fermentation; the weight ratio between strains had little effect on the fermentation results. Therefore, the weight ratio of bacterial species in each experimental group is 1:1, and the more bacterial species, the easier it is to successfully ferment, that is, the more bacterial species, the more successful the fermentation is. The higher the reproducibility of the experiment. Next, start with The 4 groups with the highest reproducibility of successful fermentation (strain combinations 11 to 14 in Table 4) were subjected to 3 repeated experiments to confirm the best fermentation conditions for different combinations of strains (that is, to achieve the highest viscosity and lowest pH in the shortest fermentation time) ), when the yogurt viscosity is higher than 100cp and the pH value is lower than 5.0, the fermentation is judged to be complete. The experimental results are shown in Table 5.

Figure 108125099-A0101-12-0013-97
Figure 108125099-A0101-12-0013-97
Figure 108125099-A0101-12-0014-98
Figure 108125099-A0101-12-0014-98

菌種組合11至14發酵製備的3重複實驗結果顯示: The results of 3 repeated experiments prepared by fermentation of the combination of strains 11 to 14 showed that:

菌種組合11:發酵溫度固定為37℃,發酵時間需12小時才能發酵完全;發酵溫度固定為40℃,發酵時間10小時能發酵完全,發酵時間8、12小時無法發酵完全;發酵溫度固定為43℃,發酵時間10、12小時能發酵完全,發酵時間越長黏度越高、pH值越低。發酵時間固定為8小時,發酵溫度37、40、43℃皆無法發酵完全;發酵時間固定為10小時,發酵溫度40、43℃能發酵完全,發酵溫度越高黏度越低、pH值越高;發酵時間固定為12小時,發酵溫度37、43℃能發酵完全。 Strain combination 11: The fermentation temperature is fixed at 37°C, and the fermentation time takes 12 hours to complete the fermentation; the fermentation temperature is fixed at 40°C, and the fermentation time is 10 hours to complete the fermentation, and the fermentation time is 8 or 12 hours to complete the fermentation; the fermentation temperature is fixed to Fermentation can be completed at 43°C and fermentation time of 10 or 12 hours. The longer the fermentation time, the higher the viscosity and the lower the pH. The fermentation time is fixed at 8 hours, and the fermentation temperature is 37, 40, and 43℃. The fermentation time is fixed at 10 hours. The fermentation temperature is 40 and 43℃, and the fermentation can be completed. The higher the fermentation temperature, the lower the viscosity and the higher the pH value; The fermentation time is fixed at 12 hours, and the fermentation temperature is 37 and 43°C to complete the fermentation.

菌種組合12:發酵溫度固定為37℃,發酵時間10、12小時皆能發酵完全,發酵時間越長黏度越高、pH值越低;發酵溫度固定為40℃,發酵時間8、10、12小時皆能發酵完全,發酵時間越長黏度越高、pH值越低;發酵溫度固定為43℃,發酵時間8、10、12小時皆能發酵完全,發酵時間越長黏度先低後高、pH值越低。發酵時間固定為8小時,發酵溫度40、43℃能發酵完全,發酵溫度越高黏度越低、pH值越高;發酵時間固定為10小時,發酵溫度37、40、43℃皆能發酵完全,發酵溫度越高黏度先高後低、pH值先低後高;發酵時間固定為12小時,發酵溫度37、40、43℃皆能發酵完全,發酵溫度越高黏度先高後低、pH值先低後高。 Strain combination 12: The fermentation temperature is fixed at 37℃, and the fermentation time is 10 or 12 hours. The fermentation time is 10 or 12 hours. The longer the fermentation time, the higher the viscosity and the lower the pH value. The fermentation temperature is fixed at 40℃, and the fermentation time is 8, 10, 12 Fermentation can be completed within hours, the longer the fermentation time, the higher the viscosity, and the lower the pH; the fermentation temperature is fixed at 43℃, and the fermentation time is 8, 10, and 12 hours. The lower the value. The fermentation time is fixed at 8 hours, the fermentation temperature is 40, 43℃, and the fermentation can be completed. The higher the fermentation temperature, the lower the viscosity and the higher the pH; the fermentation time is fixed at 10 hours, and the fermentation temperature can be completed at 37, 40, and 43℃. The higher the fermentation temperature, the higher the viscosity first, then the lower the pH value; the fermentation time is fixed at 12 hours, and the fermentation temperature is 37, 40, and 43 ℃, and the fermentation can be completed. The higher the fermentation temperature, the higher the viscosity first and then the lower pH value. High after low.

菌種組合13:發酵溫度固定為37℃,發酵時間8、10、12小時皆能發酵完全,發酵時間越長黏度越高、pH值越低;發酵溫度固定為40℃,發酵時間8、10、12小時皆能發酵完全,發酵時間越長黏度越高、pH值越低;發酵溫度固定為43℃,發酵時間8、10、12小時皆能發酵完全, 發酵時間越長黏度先低後高、pH值越低。發酵時間固定為8小時,發酵溫度37、40、43℃皆能發酵完全,發酵溫度越高黏度越高、pH值越低;發酵時間固定為10小時,發酵溫度37、40、43℃皆能發酵完全,發酵溫度越高黏度先高後低、pH值先低後高;發酵時間固定為12小時,發酵溫度37、40、43℃皆能發酵完全,發酵溫度越高黏度先低後高、pH值先低後不變。 Strain combination 13: The fermentation temperature is fixed at 37℃, and the fermentation time is 8, 10, and 12 hours. The fermentation time is 8, 10, and 12 hours. The longer the fermentation time, the higher the viscosity and the lower the pH; the fermentation temperature is fixed at 40℃, and the fermentation time is 8, 10 , The fermentation can be completed in 12 hours, the longer the fermentation time, the higher the viscosity and the lower the pH value; the fermentation temperature is fixed at 43℃, and the fermentation time can be completed in 8, 10, and 12 hours. The longer the fermentation time, the lower the viscosity and the higher the pH, and the lower the pH. The fermentation time is fixed at 8 hours, and the fermentation temperature can be completed at 37, 40, and 43°C. The higher the fermentation temperature, the higher the viscosity and the lower the pH; the fermentation time is fixed at 10 hours, and the fermentation temperature can be at 37, 40, and 43°C. Fermentation is complete. The higher the fermentation temperature, the higher the viscosity first, then the lower the pH value. The fermentation time is fixed at 12 hours, and the fermentation temperature is 37, 40, and 43 ℃. The fermentation can be completed. The higher the fermentation temperature, the viscosity first becomes lower and then higher. The pH value is low first and then unchanged.

菌種組合14:發酵溫度固定為37℃,發酵時間8、10、12小時皆能發酵完全,發酵時間越長黏度越高、pH值越低;發酵溫度固定為40℃,發酵時間8、10、12小時皆能發酵完全,發酵時間越長黏度越高、pH值越低;發酵溫度固定為43℃,發酵時間8、10、12小時皆能發酵完全,發酵時間越長黏度越高、pH值不變。發酵時間固定為8小時,發酵溫度37、40、43℃皆能發酵完全,發酵溫度越高黏度先低後高、pH值越低;發酵時間固定為10小時,發酵溫度37、40、43℃皆能發酵完全,發酵溫度越高黏度先高後低、pH值先低後不變;發酵時間固定為12小時,發酵溫度37、40、43℃皆能發酵完全,發酵溫度越高黏度先高後低、pH值先低後高。 Strain combination 14: The fermentation temperature is fixed at 37°C, and the fermentation time is 8, 10, and 12 hours. The fermentation time is 8, 10, and 12 hours. The longer the fermentation time, the higher the viscosity and the lower the pH; the fermentation temperature is fixed at 40°C, and the fermentation time is 8, 10 , The fermentation can be completed in 12 hours, the longer the fermentation time, the higher the viscosity, and the lower the pH; the fermentation temperature is fixed at 43℃, and the fermentation time can be completed in 8, 10, and 12 hours. The longer the fermentation time, the higher the viscosity and the pH. The value does not change. The fermentation time is fixed at 8 hours, and the fermentation temperature can be completed at 37, 40, and 43℃. The higher the fermentation temperature, the higher the viscosity and the lower the pH value. The fermentation time is fixed at 10 hours, and the fermentation temperature is 37, 40, and 43℃. Fermentation can be completed. The higher the fermentation temperature, the higher the viscosity first, then the lower the pH value. The fermentation time is fixed at 12 hours, and the fermentation temperature is 37, 40, and 43 ℃. The fermentation can be completed. The higher the fermentation temperature, the higher the viscosity. The latter is low, and the pH value is first low and then high.

實驗3、優格飲品的感官品評:Experiment 3. Sensory evaluation of yogurt drink:

優格對於維持身體健康具有多樣性的功效。例如,實驗證實,長期食用優格能有效降低總膽固醇以及總膽固醇與高密度脂蛋白膽固醇之比例;高膽固醇血症患者食用含嗜酸乳桿菌的優格能降低血清膽固醇;高膽固醇血症患者食用含嗜酸乳桿菌及長雙歧桿菌的優格可增加高密度膽固醇;長期食用優格可有效降低罹患糖尿病的風險;食用優格還能預防心血管疾病。因此,長期食用足夠量的優格方能達到維持身體健康功效。 Yogurt has a variety of effects for maintaining good health. For example, experiments have confirmed that long-term consumption of yogurt can effectively reduce total cholesterol and the ratio of total cholesterol to high-density lipoprotein cholesterol; patients with hypercholesterolemia eating yogurt containing Lactobacillus acidophilus can reduce serum cholesterol; patients with hypercholesterolemia Eating yogurt containing Lactobacillus acidophilus and Bifidobacterium longum can increase high-density cholesterol; long-term consumption of yogurt can effectively reduce the risk of diabetes; eating yogurt can also prevent cardiovascular disease. Therefore, long-term consumption of adequate amounts of yogurt can achieve the effect of maintaining good health.

為了達成上述目標,本發明將菌種組合1至14發酵製備為優格飲品1至14,並進行感官品評(sensory evaluation)的分析、篩選。感官品評為美國食品科技學會定義及發展出的評判基準,其應用視、嗅、嚐三種感覺來測量優格飲品的特性。感官品評的實驗設計包括:感官分析方 法總論(ISO 6658:2005)、感官品評字彙(ISO 5492:2008)、顏色感官檢驗(目視比色:ISO 11037:1999)、質地感官檢驗(質地剖面:ISO 11036:1994)、風味感官檢驗(風味剖面:ISO 6564:1985)、描述分析(感官特性的定性描述:ISO 11035:1994、感官特性強度的評估:ISO 4121:2003)。實驗方法則採用描述分析法(descriptive analysis)、順位評分法(ranking method)及喜好評分法(hedonic scale)進行評鑑。 In order to achieve the above-mentioned goal, the present invention fermented strain combinations 1-14 to prepare yogurt drinks 1-14, and performed sensory evaluation analysis and screening. The sensory product is rated as the evaluation standard defined and developed by the American Food Science and Technology Association. It uses the three senses of sight, smell and taste to measure the characteristics of yogurt drinks. The experimental design of sensory evaluation includes: sensory analysis method General Law (ISO 6658:2005), sensory evaluation vocabulary (ISO 5492:2008), color sensory inspection (visual colorimetry: ISO 11037:1999), texture sensory inspection (texture profile: ISO 11036:1994), flavor sensory inspection (Flavour profile: ISO 6564: 1985), description analysis (qualitative description of sensory characteristics: ISO 11035: 1994, evaluation of the intensity of sensory characteristics: ISO 4121: 2003). The experimental methods are evaluated by descriptive analysis, ranking method and hedonic scale.

1.以描述分析法進行優格飲品1至14的評鑑:1. Use descriptive analysis to evaluate yogurt drinks 1 to 14:

此是召集具有發酵產品開發、發酵乳製品開發、優格產品開發、手搖飲料店實務經驗之高感官敏銳性品評員11人進行實驗,其中男性5名、女性6名,以會議討論方式進行品評,判斷優格飲品間外觀、質地、風味上的差異性,最後以視(色澤、乾淨度)、嗅(奶香、香氣、氣味獨特性)、嚐(酸度、甜度、滑順度、醇厚度)、以及整體喜好(風味表現、後韻)描述差異性狀,採喜好度五分評分法(1分:非常不喜歡,2分:不喜歡,3分:不喜歡也不討厭,4分:喜歡,5分:非常喜歡)進行評價。實驗結果如表6所述。 This is to convene 11 high sensory acuity reviewers with practical experience in fermented product development, fermented dairy product development, yogurt product development, and hand-crank beverage shops to conduct the experiment, including 5 males and 6 females, which will be discussed in a meeting. Tasting, judging the differences in appearance, texture, and flavor between yogurt drinks, and finally looking at (color, cleanliness), smell (milk aroma, aroma, unique odor), taste (acidity, sweetness, smoothness, Body weight), and overall preferences (flavor performance, after rhyme) to describe the different traits, using a five-point scoring method of preference (1 point: very dislike, 2 points: dislike, 3 points: dislike or dislike, 4 points : I like it, 5 points: I like it very much) for evaluation. The experimental results are shown in Table 6.

Figure 108125099-A0101-12-0016-99
好等級高
Figure 108125099-A0101-12-0016-99
Good grade high

2.以順位評分法進行優格飲品1至14的評鑑:2. Evaluation of yogurt drinks from 1 to 14 based on the ranking method:

品評員的人數、性別如上所述,品評員依其喜好程度將優格飲品1至14區分為3個等級(喜好等級高、中、低),每個等級再依喜好程度最高至低由左至右排列。結果如表7所述。 The number and gender of the tasters are as described above. The tasters classify yogurt drinks from 1 to 14 into 3 levels (high, medium, and low) according to their preferences, and each level is based on the degree of preference from the highest to the lowest. Arrange to the right. The results are shown in Table 7.

Figure 108125099-A0101-12-0017-101
Figure 108125099-A0101-12-0017-101

3.以喜好評分法進行優格飲品11至14的評鑑:3. Evaluate yogurt drinks from 11 to 14 based on the preference score method:

將順位評分法喜好等級高的優格飲品11至14再以喜好評分法確認是否有顯著性差異、了解喜好程度與產品特性關係,以消費者問卷調查方式進行,採喜好度五分評分法(1分:非常不喜歡,2分:不喜歡,3分:不喜歡也不討厭,4分:喜歡,5分:非常喜歡)進行評分。也針對香氣、甜味、酸味,以五分制(1分:太淡,2分:淡,3分:適中,4分:濃,5分:太濃)進行紀錄,分數越接近3分越佳。 Use the preference scoring method to confirm whether there are significant differences between the yogurt drinks with high preference grades from 11 to 14 and to understand the relationship between the preference degree and product characteristics, and conduct a consumer questionnaire survey, using the preference five-point scoring method ( 1 point: dislike very much, 2 points: dislike, 3 points: dislike or dislike, 4 points: like, 5 points: like very much) for rating. The aroma, sweetness, and sourness are also recorded on a five-point system (1 point: too light, 2 points: light, 3 points: moderate, 4 points: strong, 5 points: too strong). The closer the score is to 3, the better good.

第1次消費者問卷調查於百貨公司商店街舉行,此在不受外界環境干擾、彼此不互相影響下進行。品評對象為未經訓練之消費者共67人,其中男性24人(35.8%)、女性43人(64.2%)。年齡分布為:未滿20歲25人(37.3%)、20-29歲21人(31.3%)、30-39歲13人(19.4%)、40-49歲3人(4.5%)、50-59歲4人(6%)、60歲以上1人(1.5%)。前三大職業分佈為:學生30人(44.8%)、服務業17人(25.4%)、軍公教5人(7.4%),其餘15人(22.4%)。 The first consumer questionnaire survey was held in the department store shopping street, which was conducted without interference from the external environment and mutual influence. The evaluation targets were 67 untrained consumers, including 24 men (35.8%) and 43 women (64.2%). Age distribution: 25 people (37.3%) under 20 years old, 21 people (31.3%) 20-29 years old, 13 people (19.4%) 30-39 years old, 3 people 40-49 years old (4.5%), 50- 4 persons (6%) were 59 years old and 1 person (1.5%) was 60 years old and above. The distribution of the top three occupations is: 30 students (44.8%), 17 (25.4%) in the service industry, 5 (7.4%) in the military, public education, and 15 (22.4%).

第2次消費者問卷調查於大學學區舉行,此亦在不受外界環 境干擾、彼此不互相影響下進行。品評對象為未經訓練之消費者共69人,其中男性31人(44.9%)、女性38人(55.1%)。年齡分佈為:18-22歲50人(72.5%)、23-30歲15人(21.8%)、未滿18歲4人(5.8%)。職業分佈皆為學生(69人,100%)。 The second consumer questionnaire survey was held in the university school district. Environment interference and without mutual influence. The evaluation targets were 69 untrained consumers, including 31 males (44.9%) and 38 females (55.1%). The age distribution is: 50 people (72.5%) 18-22 years old, 15 people 23-30 years old (21.8%), 4 people under 18 years old (5.8%). Occupation distribution are all students (69 people, 100%).

綜合第1次及第2次消費者問卷調查結果,參與總人數為136人。請參閱表8,整體喜好程度以優格飲品14最佳,分數為大於4分的喜歡;其次為優格飲品12;優格飲品11、13的分數相近,分數皆大於3分的不喜歡也不討厭。此外,優格飲品11、12、13及14被全部136位消費者評定為最喜好(第一順位)之優格飲品的人數分別為32、38、31及35人。 Based on the results of the first and second consumer questionnaire surveys, the total number of participants was 136. Please refer to Table 8. The overall preference is yogurt drink 14 best, with a score greater than 4, followed by yogurt drink 12. The scores of yogurt drink 11 and 13 are similar, and those with a score greater than 3 do not like it. it's OK. In addition, the number of yogurt drinks 11, 12, 13 and 14 rated by all 136 consumers as the most favorite (first order) yogurt drinks were 32, 38, 31 and 35, respectively.

Figure 108125099-A0101-12-0018-102
Figure 108125099-A0101-12-0018-102

在純天然、未加入任何調味料的製程下,優格飲品11至14的香氣差異不大,都稍微偏淡;優格飲品11至14的甜味皆適中;優格飲品11至14的酸味差異不大,都稍微偏淡(如表9結果所示)。 Under the natural process without any seasoning, the aroma of yogurt drinks 11-14 is not much different, and they are all slightly light; the sweetness of yogurt drinks 11-14 is moderate; the sour taste of yogurt drinks 11-14 The difference is not big, all are slightly lighter (as shown in the results in Table 9).

Figure 108125099-A0101-12-0018-103
Figure 108125099-A0101-12-0018-103

實驗4、優格飲品配料的感官品評:Experiment 4. Sensory evaluation of yogurt drink ingredients:

為了增加優格飲品食用上的多樣性、提高使用者每日的優格攝取量(例如能在30分鐘內喝完200g)且長期飲用不膩口,實驗4以優格飲品14為基底加入手搖飲料的配方設計,並以描述分析法進行評鑑。實 驗4召集具有發酵產品開發、發酵乳製品開發、優格產品開發、手搖飲料店實務經驗之高感官敏銳性品評員5人進行實驗,其中男性3人、女性2人,並以會議討論方式進行品評。 In order to increase the diversification of yogurt drink consumption, increase the user's daily yogurt intake (for example, can drink 200g in 30 minutes) and drink it for a long time without being greasy, experiment 4 uses yogurt drink 14 as a base to add The formulation of the shake drink is designed and evaluated by the descriptive analysis method. real Test 4 convened 5 high sensory appraisers with practical experience in fermented product development, fermented dairy product development, yogurt product development, and hand-cranked beverage shops to conduct the experiment, including 3 men and 2 women, and discuss them in a meeting. Conduct a tasting.

1.鹹甜口味的優格飲品配方設計:1. Recipe design of yogurt drink with salty and sweet taste:

加入芝麻醬為醬汁:芝麻醬熬煮後加入優格共同打碎研磨,芝麻醬香味濃郁,含有油脂,兩者相容後風味含有油脂味,使整體風味產生鹹食口感,但風味過於特異,接受度不高。加入小黃瓜為配料:小黃瓜切丁加入優格共同打碎研磨,小黃瓜風味掩蓋優格風味,整體蔬菜味明顯,缺少優格的獨特風味。加入玉米為配料:將無調味玉米罐頭之玉米粒加入優格共同打碎研磨,玉米略帶甜味,可提升整體甜味,但玉米風味與優格風味融合為一種特殊味道,接受度甚低。感官品評結果:優格飲品的配方設計不適合鹹甜口味。 Add sesame paste as the sauce: After the sesame paste is boiled, add yogurt to crush and grind together. The sesame paste has a strong fragrance and contains oil. When the two are compatible, the flavor contains oily taste, which makes the overall flavor taste salty, but the flavor is too specific and acceptable. not tall. Add cucumber as an ingredient: diced cucumber and add yogurt to crush and grind together. Cucumber flavor masks yogurt flavor. The overall vegetable taste is obvious and lacks the unique flavor of yogurt. Add corn as an ingredient: add corn kernels from canned unseasoned corn to yogurt and crush and grind together. The corn is slightly sweet, which can enhance the overall sweetness, but the corn flavor and yogurt flavor merge into a special flavor, which is very low. . Sensory evaluation result: The formula design of yogurt drink is not suitable for salty and sweet taste.

2.優格飲品醬汁的配方設計:2. The recipe design of yogurt drink sauce:

本發明的優格飲品製程純天然、且未加任何調味料,整體風味上甜味適中、香氣及酸味稍微偏淡,屬於淡雅不膩口型。不同醬汁配方帶來不同的感官感受。加入黑糖為醬汁:將熬煮成糖漿的黑糖加入優格共同打碎研磨,黑糖風味濃郁且特殊,與優格酸甜風味正好相容。加入抹茶為醬汁:將日本進口抹茶粉加入優格共同打碎研磨,抹茶微苦,與優格酸甜風味並不相容。加入蜂蜜為漿汁:將蜂蜜直接加入優格共同打碎研磨,蜂蜜特有的清香能凸顯優格的酸甜風味。 The yogurt beverage of the present invention has a pure natural process without any seasoning, and the overall flavor is moderately sweet, aroma and acidity are slightly weak, and it is elegant and not greasy. Different sauce recipes bring different sensory feelings. Add brown sugar as sauce: add the brown sugar boiled into syrup to yogurt and crush and grind together. The brown sugar has a strong and special flavor, which is just compatible with the sweet and sour flavor of yogurt. Add matcha to the sauce: add Japanese imported matcha powder to yogurt to crush and grind together. Matcha is slightly bitter and incompatible with the sweet and sour flavor of yogurt. Add honey as syrup: Add honey directly to yogurt and grind together. The unique fragrance of honey can highlight the sweet and sour flavor of yogurt.

3.優格飲品固態配料的配方設計:3. Formula design of solid ingredients of yogurt beverage:

優格飲品屬於非牛頓流體(non-Newtonian fluid,係指在某特定溫度及壓力下流體的黏滯性為非定值),其黏度會因所受壓力或速度而變化,壓力越大,黏度增加,甚至成為暫時性固體。若加入固態配料於優格飲品將造成飲用及吸食上的困難。為克服此問題,將200g優格飲品容納於圓柱杯(上圓直徑9公分,下圓直徑5.6公分,杯高13.5公分),讓使用 者可利用直徑1~1.5公分、長17.5~20公分的吸管輕鬆吸食優格飲品中的固態配料,且不會發生飲品已喝完卻殘留下固態配料的現象。在較佳實施例中,在室溫下,優格飲品的溫度升高會影響黏度進而影響以吸管吸食固態配料的難易度。因此,在優格飲品的上層加入碎冰層保冷(碎冰大小控制在0.2~0.4立方公分之間,因為小於0.2立方公分會太快融化出水,大於0.4立方公分會吸到碎冰塊口感不佳),碎冰層和優格飲品的體積比為1:3~1:5,使優格飲品在30分鐘內維持在8~12℃之間,使固態配料的感官品評結果具再現性。固態配料感官品評的評估重點為:口感的滑順度、整體的均衡度;進一步包括視覺的刺激感,提升使用者觀看而想飲用優格飲品的欲望(促進食慾、增強主動攝取)。優格飲品外觀可呈現分層、漸層、特殊紋路的效果。所添加的固態配料包括但不限於珍珠、椰果、咖啡凍、粉條、芋圓、布丁、仙草凍、豆花、綠豆、紅豆、薏仁、紫米、燕麥,其感官品評的結果如表10所述。此外,亦可使用水果作為固態配料,包括但不限於西瓜、芒果、草莓、荔枝、火龍果、百香果、酪梨、香蕉、木瓜、奇異果、柳橙、葡萄柚、鳳梨,其感官品評的結果如表11所示。 Yogurt drinks belong to non-Newtonian fluid (non-Newtonian fluid, which means that the viscosity of the fluid at a certain temperature and pressure is indeterminate), and its viscosity will change due to the pressure or speed. The higher the pressure, the higher the viscosity. Increase, and even become a temporary solid. Adding solid ingredients to yogurt beverages will cause difficulty in drinking and smoking. To overcome this problem, put 200g of yogurt drink in a cylindrical cup (upper circle diameter 9 cm, lower circle diameter 5.6 cm, cup height 13.5 cm), let use People can use a straw with a diameter of 1 to 1.5 cm and a length of 17.5 to 20 cm to easily suck the solid ingredients in the yogurt drink, and the solid ingredients will not be left after the drink has been drunk. In a preferred embodiment, at room temperature, the increase in the temperature of the yogurt drink will affect the viscosity and thus the difficulty of sucking the solid ingredients through the straw. Therefore, add a layer of crushed ice to the upper layer of the yogurt to keep cold (the size of the crushed ice should be controlled between 0.2 and 0.4 cubic centimeters, because less than 0.2 cubic centimeters will melt water too quickly, and more than 0.4 cubic centimeters will suck the crushed ice cubes. Good), the volume ratio of the crushed ice layer and the yogurt drink is 1:3~1:5, so that the yogurt drink can be maintained at 8~12℃ within 30 minutes, so that the sensory evaluation results of the solid ingredients are reproducible. The key points of the sensory evaluation of solid ingredients are: smoothness of taste and overall balance; further including visual stimulation, which enhances the user's desire to drink yogurt beverages (promoting appetite and enhancing active intake). The appearance of yogurt drinks can show the effects of layering, gradation, and special textures. The added solid ingredients include, but are not limited to, pearl, coconut, coffee jelly, vermicelli, taro balls, pudding, grass jelly, bean curd, mung bean, red bean, coix seed, purple rice, oats, and the sensory evaluation results are shown in Table 10. Narrated. In addition, fruits can also be used as solid ingredients, including but not limited to watermelon, mango, strawberry, lychee, dragon fruit, passion fruit, avocado, banana, papaya, kiwi, orange, grapefruit, and pineapple. The results are shown in Table 11.

Figure 108125099-A0101-12-0020-104
Figure 108125099-A0101-12-0020-104
Figure 108125099-A0101-12-0021-105
Figure 108125099-A0101-12-0021-105
Figure 108125099-A0101-12-0022-106
Figure 108125099-A0101-12-0022-106

Figure 108125099-A0101-12-0022-107
Figure 108125099-A0101-12-0022-107
Figure 108125099-A0101-12-0023-108
Figure 108125099-A0101-12-0023-108
Figure 108125099-A0101-12-0024-110
Figure 108125099-A0101-12-0024-110

實驗5、優格飲品萃取物的製備:Experiment 5. Preparation of Yogurt Drink Extract:

優格飲品活性代謝物的種類及含量受菌種、配方、發酵環境而有所差異。為了確定本發明的優格飲品的活性成分,選擇感官品評喜好等級高的優格飲品11至14進行萃取及分配萃取,將獲得的劃分層再進行成分分析及活性測試。 The types and content of active metabolites of yogurt drinks vary by strain, formula, and fermentation environment. In order to determine the active ingredients of the yogurt drink of the present invention, yogurt drinks 11 to 14 with high sensory preference ratings are selected for extraction and distribution extraction, and the obtained divided layers are then subjected to component analysis and activity testing.

1.分離方法1:1. Separation method 1:

將優格飲品原液以加熱減壓濃縮進行乾燥,獲得膏狀物。再以乙醇連續萃取膏狀物3次,獲得乙醇萃取物。將該乙醇萃取物真空過濾,並加熱、減壓濃縮,獲得粗萃取物。再以乙酸乙酯:水(1:1(v/v))對粗萃取物進行分配萃取。但粗萃取物乳化層太多,導致分離效果不佳,無法進行後續分離實驗。若改以二氯甲烷:水(1:1(v/v))對粗萃取物進行分配萃取,仍有乳化層太多的問題。 The yogurt drink stock solution is heated under reduced pressure, concentrated and dried to obtain a paste. Then the paste was continuously extracted 3 times with ethanol to obtain an ethanol extract. The ethanol extract was vacuum filtered, heated and concentrated under reduced pressure to obtain a crude extract. The crude extract was partitioned and extracted with ethyl acetate: water (1:1 (v/v)). However, there are too many emulsified layers of the crude extract, resulting in poor separation effect, and subsequent separation experiments cannot be carried out. If it is changed to dichloromethane: water (1:1 (v/v)) to partition and extract the crude extract, there is still a problem of too much emulsified layer.

2.分離方法2:2. Separation method 2:

將優格飲品原液不經乾燥,而是加水(1:1(v/v))稀釋,再加入乙酸乙酯(1:1(v/v))進行分配萃取,仍產生大量乳化層,導致分離效果不佳。若改為加入二氯甲烷(1:1(v/v))或者正丁醇(1:1(v/v))進行分配萃取,仍有乳化層太多的問題。 The yogurt drink stock solution is not dried, but diluted with water (1:1(v/v)), and then ethyl acetate (1:1(v/v)) is added for distribution extraction, which still produces a large amount of emulsified layer, resulting in The separation effect is not good. If dichloromethane (1:1(v/v)) or n-butanol (1:1(v/v)) is added instead for partition extraction, there is still a problem of too much emulsified layer.

3.分離方法3:3. Separation method 3:

將優格飲品原液進行冷凍乾燥,獲得粉狀產物,再將粉狀產物以極性漸增的溶媒依序進行萃取。發現二氯甲烷的萃取率太低、和正己烷的萃取效果無顯著差異,以正丁醇萃取後有溶媒殘留的問題、難接續後續的溶媒萃取,故二氯甲烷、正丁醇皆不適合作為此分離方法的萃取溶媒。 The yogurt drink stock solution is freeze-dried to obtain a powdered product, and then the powdered product is sequentially extracted with a solvent with increasing polarity. It is found that the extraction rate of dichloromethane is too low, and there is no significant difference in the extraction effect of n-hexane. After extraction with n-butanol, there is a problem of residual solvent and it is difficult to continue the subsequent solvent extraction. Therefore, dichloromethane and n-butanol are not suitable for use. The extraction solvent for this separation method.

如第5圖所示的分離方法3,經溶媒排列組合萃取試驗後,最後以正己烷、乙酸乙酯、乙醇及水依序進行萃取。亦即,優格飲品原液12進行冷凍乾燥,獲得粉狀產物14,再以正己烷萃取粉狀產物14,獲得正己烷萃取物16(樣品代號:11-H、12-H、13-H、14-H)及第一殘留物18。接著,以乙酸乙酯萃取第一殘留物18,獲得乙酸乙酯萃取物20(樣品代號:11-E、12-E、13-E、14-E)及第二殘留物22。之後,以乙醇萃取第二殘留物22,獲得乙醇萃取物24(樣品代號:11-A、12-A、13-A、14-A)及第三殘留物26。最後,再以水萃取第三殘留物26,獲得水萃取物28(樣品代號:11-W、12-W、13-W、14-W)及第四殘留物30。萃取物及殘留物並得各自進行加熱減壓濃縮。優格飲品11至14的各種萃取物的實驗結果如表12所 示。表12顯示:此分離方法能克服液態-液態分配萃取產生乳化層的問題,將優格飲品的各類活性成分分離、濃縮集中收集,並得以視覺、嗅覺明顯確認各種萃取物在外觀性狀、風味上的差異。 As shown in the separation method 3 shown in Figure 5, after the solvent permutation and combination extraction test, the final extraction is carried out in order with n-hexane, ethyl acetate, ethanol and water. That is, the yogurt drink stock solution 12 is freeze-dried to obtain a powdered product 14, and then the powdered product 14 is extracted with n-hexane to obtain a n-hexane extract 16 (sample code: 11-H, 12-H, 13-H, 14-H) and the first residue 18. Then, the first residue 18 is extracted with ethyl acetate to obtain the ethyl acetate extract 20 (sample code: 11-E, 12-E, 13-E, 14-E) and the second residue 22. After that, the second residue 22 is extracted with ethanol to obtain an ethanol extract 24 (sample code: 11-A, 12-A, 13-A, 14-A) and a third residue 26. Finally, the third residue 26 is extracted with water to obtain the water extract 28 (sample code: 11-W, 12-W, 13-W, 14-W) and the fourth residue 30. The extract and residue must be heated and concentrated under reduced pressure. The experimental results of various extracts of yogurt drinks from 11 to 14 are shown in Table 12. Show. Table 12 shows that this separation method can overcome the problem of liquid-liquid distribution and extraction to produce an emulsified layer. It separates, concentrates and collects various active ingredients of yogurt beverages, and visually and olfactorily confirms the appearance and flavor of various extracts. The difference.

Figure 108125099-A0101-12-0026-111
Figure 108125099-A0101-12-0026-111

實驗6、優格飲品萃取物的成分分析:Experiment 6. Component analysis of yogurt drink extract:

1.核磁共振光譜(NMR)分析:1. Nuclear magnetic resonance spectroscopy (NMR) analysis:

優格飲品11至14經分離方法3獲得16個萃取物,將這些萃取物進行NMR分析,以氫的同位素(氘)溶劑:CDCl3、acetone-d6、MeOH-d4、C5D5N、DMSO-d6及D2O測試萃取物的溶解度,結果發現C5D5N、DMSO-d6對於16個萃取物皆有較佳的溶解度。在1H-NMR預實驗中發現C5D5N的溶媒訊號會遮蔽萃取物的訊號,最後選擇DMSO-d6作為NMR分析的溶劑,萃取物的濃度為25mg/ml、50mg/ml、75mg/ml及100mg/ml。發現正己烷萃取物(11-H、12-H、13-H、14-H)、乙酸乙酯萃取物(11-E、12-E、13-E、14-E)、乙醇萃取物(樣品代號:11-A、12-A、13-A、14-A)在50mg/ml時的1H-NMR圖譜顯示出最佳磁場及特徵訊號,水萃取物(11-W、12-W、13-W、14-W)的最佳樣品濃度為25mg/ml。正己烷萃取物(11-H、12-H、13-H、14-H)及乙酸乙酯萃取物(11-E、12-E、13-E、14-E)在加入DMSO-d6後、測試前,加熱至37~40℃能再提高樣品溶解度、進而優化1H-NMR圖譜的特徵訊號。以核磁共振光譜儀JEOL ECS 400MHz FT-NMR進行實驗,解析度為400MHz,化學位移以ppm(δ)表示,偶合常數(coupling constants)以Hertz(J)表示。如第6圖(A)至第9圖(D)的16個萃取物的1H-NMR圖譜及表13的16個萃取物的NMR訊號分析及主量成分判定所示,正己烷萃取物、乙酸乙酯萃取物、乙醇萃取物、水萃取物的NMR特徵訊號及主量成分皆不相同,優格飲品11至14之間的NMR訊號亦有所差異。 The yogurt drinks 11 to 14 obtained 16 extracts by separation method 3. These extracts were analyzed by NMR, and the hydrogen isotopes (deuterium) solvents: CDCl 3 , acetone-d6, MeOH-d4, C 5 D 5 N, The solubility of the extracts was tested by DMSO-d6 and D 2 O, and it was found that C 5 D 5 N and DMSO-d6 had better solubility for the 16 extracts. In the 1 H-NMR preliminary experiment, it was found that the solvent signal of C 5 D 5 N would obscure the signal of the extract. Finally, DMSO-d6 was selected as the solvent for NMR analysis. The concentration of the extract was 25mg/ml, 50mg/ml, 75mg/ ml and 100mg/ml. Found n-hexane extract (11-H, 12-H, 13-H, 14-H), ethyl acetate extract (11-E, 12-E, 13-E, 14-E), ethanol extract ( Sample code: 11-A, 12-A, 13-A, 14-A) 1 H-NMR spectrum at 50mg/ml shows the best magnetic field and characteristic signal, water extract (11-W, 12-W , 13-W, 14-W) the best sample concentration is 25mg/ml. Hexane extract (11-H, 12-H, 13-H, 14-H) and ethyl acetate extract (11-E, 12-E, 13-E, 14-E) after adding DMSO-d6 、Before the test, heating to 37~40℃ can further improve the solubility of the sample, and then optimize the characteristic signal of the 1 H-NMR spectrum. The experiment was carried out with a JEOL ECS 400MHz FT-NMR with a resolution of 400MHz, chemical shifts were expressed in ppm (δ), and coupling constants were expressed in Hertz ( J ). As shown in the 1 H-NMR spectra of the 16 extracts in Figure 6 (A) to Figure 9 (D) and the NMR signal analysis and main component determination of the 16 extracts in Table 13, the n-hexane extract, The NMR characteristic signals and main components of ethyl acetate extract, ethanol extract, and water extract are all different, and the NMR signals of yogurt drinks 11 to 14 are also different.

Figure 108125099-A0101-12-0027-112
Figure 108125099-A0101-12-0027-112
Figure 108125099-A0101-12-0028-113
Figure 108125099-A0101-12-0028-113
Figure 108125099-A0101-12-0029-114
Figure 108125099-A0101-12-0029-114

2.總多酚(total polyphenol)含量分析:2. Analysis of total polyphenol content:

優格飲品11至14經分離方法3獲得16個萃取物,將這些萃取物以Folin-Ciocalteu比色法進行分析,其原理為Folin-Ciocalteu試劑中的磷鎢酸(phosphotungstic acid)及磷鉬酸(phosphomolybdic acid)被多酚類分子氧化呈色,並以没食子酸(gallic acid)作為標準品。實驗方法為:以甲醇溶解没食子酸(5mg/mL)後,製成50、100、250及500μg/mL的標準品,各取20μL標準品以二次水將體積補充至1.6mL,接著加入100μL的2N Folin-Ciocalteu試劑、再加入300μL的20% Na2CO3後並混合,在40℃反應40分鐘,於725nm下測定吸光值。此外另以二次水代替標準品,進行歸零。以濃度及吸光值之關係繪製標準曲線。20μL的待測樣品(1mg/mL)以相同方式處理,依標準曲線計算每克萃取物中總多酚類含量。如表14及第10圖所示的總多酚含量,優格飲品11的萃取物中,11-E含量最高,11-W最低;優格飲品12的萃取物中,12-A含量最高,12-W最低;優格飲品13的萃取物中,13-H含量最高,13-W最低;優格飲品14的萃取物中,14-E含量最高,14-W最低。綜合16個萃取物,14-E的總多酚含量最高,11-W最低。4個正己烷萃取物(11-H至14-H)中,總多酚含量範圍為18.2~24.0mgGallic acid/g。4個乙酸乙酯萃取物(11-E至14-E)中,總多酚含量範圍為9.4~40.6mgGallic acid/g。4個乙醇萃取物(11-A至14-A)中,總多酚含量範圍為11.3~28.3mgGallic acid/g。4個水萃取物(11-W至14-W)中,總多酚含量範圍為2.6~7.1mgGallic acid/g。 The yogurt drinks 11 to 14 were separated by method 3 to obtain 16 extracts. These extracts were analyzed by the Folin-Ciocalteu colorimetric method. The principle is the phosphotungstic acid and phosphomolybdic acid in the Folin-Ciocalteu reagent. (phosphomolybdic acid) is oxidized by polyphenol molecules to show color, and gallic acid is used as the standard product. The experimental method is: after dissolving gallic acid (5mg/mL) in methanol, make 50, 100, 250 and 500μg/mL standard products, take 20μL of each standard product and supplement the volume to 1.6mL with secondary water, and then add 100μL 2N Folin-Ciocalteu reagent, and then add 300μL of 20% Na 2 CO 3 and mix, react at 40°C for 40 minutes, and measure the absorbance at 725nm. In addition, the standard product was replaced with secondary water for zeroing. Draw a standard curve based on the relationship between concentration and absorbance. 20μL of the test sample (1mg/mL) was processed in the same way, and the total polyphenol content in each gram of extract was calculated according to the standard curve. As shown in Table 14 and Figure 10, the extract of Yogurt Drink 11 has the highest content of 11-E and the lowest 11-W; the Extract of Yogurt Drink 12 has the highest content of 12-A. 12-W is the lowest; in the extract of Yogurt Drink 13, the content of 13-H is the highest and 13-W is the lowest; in the extract of Yogurt Drink 14, the content of 14-E is the highest and 14-W is the lowest. Taking 16 extracts together, 14-E has the highest total polyphenol content and 11-W the lowest. In the 4 n-hexane extracts (11-H to 14-H), the total polyphenol content ranged from 18.2~24.0mg Gallic acid /g. In the 4 ethyl acetate extracts (11-E to 14-E), the total polyphenol content ranged from 9.4~40.6mg Gallic acid /g. In the 4 ethanol extracts (11-A to 14-A), the total polyphenol content ranged from 11.3~28.3mg Gallic acid /g. In the 4 water extracts (11-W to 14-W), the total polyphenol content ranges from 2.6 to 7.1 mg Gallic acid /g.

Figure 108125099-A0101-12-0030-115
Figure 108125099-A0101-12-0030-115
Figure 108125099-A0101-12-0031-116
Figure 108125099-A0101-12-0031-116

3.總flavanone類黃酮含量分析:3. Analysis of total flavanone flavonoid content:

原理為2,4-二硝基苯肼(2,4-dinitrophenylhydrazine,DNP)會針對黃烷酮(flavanone)結構上的醛基或酮基進行衍生化,使其在特定波長下具有吸光特性,並以橙皮素(hesperetin)為標準品。實驗方法為:將1mL待測樣品加入2mL的DNP溶液及2mL甲醇,置於50℃水浴加熱50分鐘。冷卻後加入5mL的KOH甲醇溶液混合,室溫下靜置2分鐘,再將1mL混合溶液裝至含5mL甲醇的離心瓶,振盪後以1108×g離心10分鐘。過濾後的上清液以甲醇定量至25mL,並在波長494nm測定吸光值。測定之吸光值與標準品的標準曲線對照定量,換算成每克萃取物之flavanone類黃酮含量。如表14及第11圖所示的總flavanone類黃酮測定結果,優格飲品11的萃取物中,11-A含量最高,11-E最低;優格飲品12的萃取物中,12-A含量最高,12-H最低;優格飲品13的萃取物中,13-A含量最高,13-H最低;優格飲品14的萃取物中,14-A含量最高,14-H最低。綜合16個萃取物,12-A的總flavanone類黃酮含量最高,12-H最低。4個正己烷萃取物(11-H至14-H)中,總flavanone類黃酮含量範圍為15.0~23.1mgHesperetin/g。4個乙酸乙酯萃取物(11-E至14-E)中,總flavanone類黃酮含量範圍為16.0~26.0mgHesperetin/g。4個乙醇萃取物(11-A至14-A)中,總flavanone類黃酮含量範圍為62.5~91.3mgHesperetin/g。4個水萃取物 (11-W至14-W)中,總flavanone類黃酮含量範圍為28.2~49.5mgHesperetin/g。 The principle is that 2,4-dinitrophenylhydrazine (2,4-dinitrophenylhydrazine, DNP) will derivatize the aldehyde or ketone group on the flavanone structure to make it absorb light at a specific wavelength. And hesperetin (hesperetin) as the standard product. The experimental method is as follows: add 1 mL of the sample to be tested into 2 mL of DNP solution and 2 mL of methanol, and place it in a 50°C water bath to heat for 50 minutes. After cooling, add 5 mL of KOH methanol solution and mix, let stand at room temperature for 2 minutes, then put 1 mL of the mixed solution into a centrifuge bottle containing 5 mL of methanol, shake and centrifuge at 1108×g for 10 minutes. The filtered supernatant was quantified to 25 mL with methanol, and the absorbance was measured at a wavelength of 494 nm. The measured absorbance value is compared with the standard curve of the standard product and converted into the content of flavanone flavonoids per gram of extract. As shown in Table 14 and Figure 11, the total flavanone flavonoid determination results show that in the extract of Yogurt Drink 11, the content of 11-A is the highest and 11-E is the lowest; in the extract of Yogurt Drink 12, the content of 12-A is The highest, 12-H is the lowest; in the extract of Yogurt Drink 13, the content of 13-A is the highest, and the content of 13-H is the lowest; in the extract of Yogurt Drink 14, the content of 14-A is the highest and 14-H is the lowest. Combining 16 extracts, 12-A has the highest total flavanone flavonoid content, and 12-H has the lowest content. In the 4 n-hexane extracts (11-H to 14-H), the total flavanone flavonoid content ranged from 15.0-23.1mg Hesperetin /g. In the 4 ethyl acetate extracts (11-E to 14-E), the total flavanone flavonoid content ranged from 16.0~26.0mg Hesperetin /g. In the 4 ethanol extracts (11-A to 14-A), the total flavanone flavonoid content ranged from 62.5 to 91.3 mg Hesperetin /g. In the 4 water extracts (11-W to 14-W), the total flavanone flavonoid content ranged from 28.2 to 49.5 mg Hesperetin /g.

4.總多醣含量分析:4. Analysis of total polysaccharide content:

此分析是以苯酚-硫酸法(phenol-sulfuric acid assay)進行,原理為五碳糖及六碳糖在酸性、高溫的條件下會因脫水作用分解成喃甲醛(furfural),喃甲醛進一步與酚反應生成橘黃色產物,以吸光值變化換算出總多醣含量,並以0、10、20、30、40、50μg/ml葡萄糖為標準品。實驗方法為:將0.5mL的5%酚溶液加入0.5mL的10mg/mL待測品,再加入2.5mL濃硫酸混合均勻,於100℃水浴反應20分鐘,溫度冷卻後以490nm波長測定吸光值。如表14及第12圖所示的總多醣測定結果,優格飲品11的萃取物中,11-W含量最高,11-H最低;優格飲品12的萃取物中,12-W含量最高,12-E最低;優格飲品13的萃取物中,13-W含量最高,13-H最低;優格飲品14的萃取物中,14-W含量最高,14-H最低。綜合16個萃取物,14-W的總多醣含量最高,14-H最低。4個正己烷萃取物(11-H至14-H)的總多醣含量範圍為7.6~11.2mgGlucose/g。4個乙酸乙酯萃取物(11-E至14-E)的總多醣含量範圍為9.7~18.4mgGlucose/g。4個乙醇萃取物(11-A至14-A)的總多醣含量範圍為223.2~249.4mgGlucose/g。4個水萃取物(11-W至14-W)的總多醣含量範圍為414.4~494.1mgGlucose/g。 This analysis is carried out by the phenol-sulfuric acid assay. The principle is that the five-carbon and six-carbon sugars will be decomposed into furfural due to dehydration under acidic and high-temperature conditions. The furfural is further combined with phenol. The reaction produces an orange product. The total polysaccharide content is calculated by the change in absorbance, and 0, 10, 20, 30, 40, 50 μg/ml glucose is used as the standard product. The experimental method is as follows: add 0.5mL of 5% phenol solution to 0.5mL of 10mg/mL test product, then add 2.5mL of concentrated sulfuric acid to mix uniformly, react in a water bath at 100℃ for 20 minutes, and measure the absorbance at a wavelength of 490nm after cooling the temperature. As shown in Table 14 and Figure 12, the total polysaccharide determination results show that in the extract of Yogurt Drink 11, 11-W has the highest content and 11-H is the lowest; in the extract of Yogurt Drink 12, 12-W has the highest content. 12-E is the lowest; in the extract of Yogurt Drink 13, the content of 13-W is the highest and 13-H is the lowest; in the extract of Yogurt Drink 14, the content of 14-W is the highest and 14-H is the lowest. Combining 16 extracts, 14-W has the highest total polysaccharide content and 14-H the lowest. The total polysaccharide content of the 4 n-hexane extracts (11-H to 14-H) ranges from 7.6 to 11.2 mg Glucose /g. The total polysaccharide content of the 4 ethyl acetate extracts (11-E to 14-E) ranges from 9.7 to 18.4 mg Glucose /g. The total polysaccharide content of the 4 ethanol extracts (11-A to 14-A) ranges from 223.2~249.4mg Glucose /g. The total polysaccharide content of the 4 water extracts (11-W to 14-W) ranges from 414.4 to 494.1 mg Glucose /g.

5.薄層層析(TLC)分析:5. Thin layer chromatography (TLC) analysis:

參照台灣中藥典(第二版)中常用的正相薄層層析法進行分析,溶媒系統以離子性溶媒系統(正己烷、二氯甲烷、三氯甲烷、甲醇)或非離子性溶媒系統(正己烷、甲苯、乙酸乙酯、丙酮、甲醇)、以及加酸(冰醋酸(GAA)、甲酸(FA))或加鹼(10%氨、25%氨、二乙胺)搭配進行測試。如表15所示,正己烷萃取物及乙酸乙酯萃取物(11-H、11-E、12-H、12-E、13-H、13-E、14-H、14-E)的極性較為相近,TLC主要斑點能在同一溶媒系統具有良好的分析效果。乙醇萃取物(11-A至14-A)及水萃取物(11-W至14-W)在正相薄層層析中皆無理想的分析效果,TLC主 要斑點未能存在於Rf 0.3-0.8。 Refer to the normal phase thin layer chromatography commonly used in the Taiwan Chinese Pharmacopoeia (Second Edition) for analysis. The solvent system is an ionic solvent system (n-hexane, dichloromethane, chloroform, methanol) or a non-ionic solvent system ( N-hexane, toluene, ethyl acetate, acetone, methanol), and adding acid (glacial acetic acid (GAA), formic acid (FA)) or alkali (10% ammonia, 25% ammonia, diethylamine) for testing. As shown in Table 15, the n-hexane extract and ethyl acetate extract (11-H, 11-E, 12-H, 12-E, 13-H, 13-E, 14-H, 14-E) The polarities are relatively similar, and the main spots of TLC can have a good analysis effect in the same solvent system. Ethanol extracts (11-A to 14-A) and water extracts (11-W to 14-W) have no ideal analytical results in normal phase thin layer chromatography, and the main spots of TLC cannot be found in R f 0.3- 0.8.

Figure 108125099-A0101-12-0033-117
Figure 108125099-A0101-12-0033-117
Figure 108125099-A0101-12-0034-118
Figure 108125099-A0101-12-0034-118

6.高效液相層析(HPLC)分析:6. High performance liquid chromatography (HPLC) analysis:

參照台灣中藥典(第二版)中常用的逆相高效液相層析法進行分析,條件如下:高效液相層析儀為Agilent 1100系列,偵測器為G1315B光二極體陣列偵測器,自動取樣器為G1329A自動取樣器,層析管柱為 Intersil ODS-3V 250 x 4.6mm(5μm),移動相的溶劑A為乙腈、溶劑B為0.1% H3PO4,流速為1ml/min,管柱溫度為30℃,偵測波長為203、210、254、280及365nm。溶媒系統條件如下:移動相包括溶劑A及B、線性梯度為0~20分鐘0% A~10% A,20~40分鐘10% A~40% A,40~60分鐘40% A~100% A,60~70分鐘100% A,流速及管柱溫度如上所述。如表16及第13圖至第16圖所示,5種偵測波長中,正己烷萃取物(11-H至14-H)及乙酸乙酯萃取物(11-E至14-E)皆未觀察到顯著的層析波峰,乙醇萃取物(11-A至14-A)及水萃取物(11-W至14-W)只有203nm呈現較佳的層析波峰。 Analyze with reference to the reverse phase high performance liquid chromatography method commonly used in Taiwan Chinese Pharmacopoeia (Second Edition). The conditions are as follows: the high performance liquid chromatograph is Agilent 1100 series, and the detector is G1315B photodiode array detector. The autosampler is G1329A autosampler, the chromatography column is Intersil ODS-3V 250 x 4.6mm (5μm), the mobile phase solvent A is acetonitrile, solvent B is 0.1% H 3 PO 4 , and the flow rate is 1ml/min. The column temperature is 30°C, and the detection wavelengths are 203, 210, 254, 280 and 365nm. The conditions of the solvent system are as follows: the mobile phase includes solvents A and B, the linear gradient is 0~20 minutes, 0% A~10% A, 20~40 minutes, 10% A~40% A, 40~60 minutes, 40% A~100% A, 100% A for 60~70 minutes, the flow rate and column temperature are as described above. As shown in Table 16 and Figures 13 to 16, among the 5 detection wavelengths, the n-hexane extract (11-H to 14-H) and the ethyl acetate extract (11-E to 14-E) are both No significant chromatographic peak was observed. The ethanol extract (11-A to 14-A) and the water extract (11-W to 14-W) only showed a better chromatographic peak at 203nm.

Figure 108125099-A0101-12-0035-119
Figure 108125099-A0101-12-0035-119

實驗7、優格飲品萃取物的抗氧化活性測試:Experiment 7. Antioxidant activity test of yogurt drink extract:

1.清除1,1-二苯基-2-三硝基苯肼(2,2-diphenyl-1-pricrylhydrazyl,DPPH)自由基能力測定:1. Determination of the ability to scavenge 1,1-diphenyl-2-trinitrophenylhydrazine (2,2-diphenyl-1-pricrylhydrazyl, DPPH) free radicals:

脂質在自行氧化過程中產生自由基而造成脂質酸敗,抗氧化物藉由提供氫來清除脂質過氧化物自由基,進而抑制氧化連鎖反應。DPPH在抗氧化研究中常被使用來評估抗氧化物的供氫能力。DPPH甲醇溶液在517nm有強吸光,被抗氧化劑還原時吸光值降低。因此,在517nm的吸光值越低表示抗氧化劑的供氫能力越強。實驗方法為:將4mL的萃取物樣品(50mg的萃取物溶於15mL的50%乙醇溶液)加入1mL新鮮配製的10 mM DPPH甲醇溶液,振盪混合後置於室溫30分鐘,檢測517nm波長的吸光值。結果以清除百分比表示,清除百分比越高表示測試樣品的供氫能力越佳。如表17及第17圖所示,萃取物11-A、14-A在16個萃取物中具有較佳的清除DPPH自由基能力。 Lipids generate free radicals in the process of self-oxidation to cause lipid rancidity. Antioxidants provide hydrogen to scavenge lipid peroxide free radicals, thereby inhibiting the chain reaction of oxidation. DPPH is often used in antioxidant research to evaluate the hydrogen supply capacity of antioxidants. DPPH methanol solution has a strong absorbance at 517nm, and the absorbance decreases when it is reduced by antioxidants. Therefore, the lower the absorbance value at 517 nm, the stronger the hydrogen supply capacity of the antioxidant. The experimental method is: add 4 mL of extract sample (50 mg of extract dissolved in 15 mL of 50% ethanol solution) to 1 mL of freshly prepared 10 mM DPPH methanol solution, shake and mix, place at room temperature for 30 minutes, and detect the absorbance at 517nm wavelength. The result is expressed as a removal percentage, and the higher the removal percentage, the better the hydrogen supply capacity of the test sample. As shown in Table 17 and Figure 17, the extracts 11-A and 14-A have better DPPH free radical scavenging ability among the 16 extracts.

Figure 108125099-A0101-12-0036-120
Figure 108125099-A0101-12-0036-120

2.總抗氧化能力(trolox equivalent antioxidant capacity,TEAC)測定:2. Determination of total antioxidant capacity (trolox equivalent antioxidant capacity, TEAC):

2,2'-Azinobis-(3-ethylbenzthiazoline-6-sulphonate)(ABTS)在過氧化氫、過氧化酶催化下產生氧化反應,形成穩定的藍綠色水溶性ABTS˙+陽離子自由基。使用紫外光-可見光光度計、在620nm下有較強吸光值,對照標準品水溶性維他命E類似物(trolox)製作標準曲線。當ABTS˙+陽離子自由基與抗氧化劑還原時,溶液顏色會變淺、吸光值降低,從而換算清除ABTS˙+陽離子自由基之能力。清除能力越好表示抗氧化物供氫能力 越強。實驗方法為:將配製完成後的ABTS置於冰箱1小時,使其產生穩定的藍綠色ABTS˙+自由基水溶液。將80μL萃取物樣品(50mg的萃取物溶於15mL的50%乙醇溶液)加入96孔盤,再加入120μL的ABTS˙+自由基水溶液,總體積為200μL。於室溫下避光震盪10分鐘,測定620nm的吸光值。吸光值越低表示清除ABTS˙+自由基效果越佳,以百分比計算清除率。如表17及第18圖所示的總抗氧化能力結果,優格飲品11的萃取物中,11-A能力最佳,11-E最弱;優格飲品12的萃取物中,12-A能力最佳,12-H最弱;優格飲品13的萃取物中,13-A能力最佳,13-H最弱;優格飲品14的萃取物中,14-A能力最佳,14-H最弱。在16個萃取物中,12-A的總抗氧化能力最佳,12-H最弱。 2,2'-Azinobis-(3-ethylbenzthiazoline-6-sulphonate) (ABTS) produces an oxidation reaction catalyzed by hydrogen peroxide and peroxidase to form a stable blue-green water-soluble ABTS + cationic radical. Use an ultraviolet-visible photometer, with a strong absorbance value at 620nm, and make a standard curve with a standard water-soluble vitamin E analogue (trolox). When ABTS˙ + cationic free radicals are reduced with antioxidants, the color of the solution will become lighter and the light absorption value will decrease, which can be converted into the ability to remove ABTS˙ + cationic free radicals. The better the scavenging ability, the stronger the antioxidant hydrogen supply ability. The experimental method is: put the prepared ABTS in the refrigerator for 1 hour to produce a stable blue-green ABTS + free radical aqueous solution. Add 80 μL of the extract sample (50 mg of the extract dissolved in 15 mL of 50% ethanol solution) into a 96-well plate, and then add 120 μL of ABTS˙ + free radical aqueous solution, with a total volume of 200 μL. Shake for 10 minutes in the dark at room temperature, and measure the absorbance at 620 nm. The lower the absorbance value, the better the removal of ABTS˙ + free radicals. The removal rate is calculated as a percentage. As shown in the results of total antioxidant capacity shown in Table 17 and Figure 18, among the extracts of Yogurt Drink 11, 11-A has the best ability and 11-E is the weakest; among the extracts of Yogurt Drink 12, 12-A The best ability, 12-H is the weakest; among the extracts of yogurt drink 13, 13-A has the best ability and 13-H is the weakest; among the extracts of yogurt drink 14, 14-A has the best ability, 14- H is the weakest. Among the 16 extracts, 12-A has the best total antioxidant capacity and 12-H the weakest.

3.還原力測定:3. Determination of reducing power:

抗氧化劑會將赤血鹽(K3Fe(CN)6)還原成黃血鹽(K4Fe(CN)6),黃血鹽再與Fe3+作用生成普魯士藍,在620nm波長測定吸光值,以檢測普魯士藍之生成量,吸光值愈高表示抗氧化劑還原力愈強。實驗方法為:將200μL萃取物樣品(50mg的萃取物溶於15mL的50%乙醇溶液)加入微量離心管,再加入200μL的1%赤血鹽,總體積為400μL。混合後置於50℃水浴槽反應20分鐘,反應完成後置於冰上冷卻10分鐘,再加入200μL的10%三氯乙酸(TCA)混合,以3,000rpm離心10分鐘。將75μL上清液加入96孔盤,再加入75μL超純水及30μL的0.1% FeCl3.6H2O,混合後測定620nm吸光值。吸光值越高代表還原力越強。如表17及第19圖所示,優格飲品11的萃取物中,11-A還原力最佳,11-H及11-E的還原力相等且最弱;優格飲品12的萃取物中,12-A還原力最佳,12-W最弱;優格飲品13的萃取物中,13-A還原力最佳,13-H最弱;優格飲品14的萃取物中,14-A還原力最佳,14-H還原力最弱。在16個萃取物中,12-A還原力最佳,13-H還原力最弱。 Antioxidants will reduce the red blood salt (K 3 Fe(CN) 6 ) to yellow blood salt (K 4 Fe(CN) 6 ), and the yellow blood salt will react with Fe 3+ to produce Prussian blue. The absorbance value is measured at 620nm. , To detect the amount of Prussian blue produced, the higher the absorbance value, the stronger the reducing power of the antioxidant. The experimental method is: add 200 μL of extract sample (50 mg of extract dissolved in 15 mL of 50% ethanol solution) into a microcentrifuge tube, and then add 200 μL of 1% red blood salt, the total volume is 400 μL. After mixing, place it in a 50°C water bath for 20 minutes. After the reaction is completed, place it on ice to cool for 10 minutes, then add 200 μL of 10% trichloroacetic acid (TCA) to mix, and centrifuge at 3,000 rpm for 10 minutes. Add 75μL of supernatant to a 96-well plate, then add 75μL of ultrapure water and 30μL of 0.1% FeCl 3 . 6H 2 O, after mixing, measure the absorbance at 620 nm. The higher the absorbance value, the stronger the reducing power. As shown in Table 17 and Figure 19, among the extracts of Yogurt Drink 11, 11-A has the best reducing power, while 11-H and 11-E have the same reducing power and the weakest; among the extracts of Yogurt Drink 12 , 12-A has the best reducing power and 12-W is the weakest; among the extracts of yogurt drink 13, 13-A has the best reducing power and 13-H is the weakest; among the extracts of yogurt drink 14, 14-A The reducing power is the best, and the 14-H reducing power is the weakest. Among the 16 extracts, 12-A has the best reducing power and 13-H has the weakest reducing power.

實驗8、優格飲品萃取物的抑制癌細胞生長活性測試:Experiment 8. Test of inhibiting cancer cell growth activity of Yogurt drink extract:

針對共生菌-腸-腦軸的相關器官,活性代謝物自口腔攝入開始,會經由消化道、血液、循環系統、至泌尿系統(排泄系統),選擇以口腔癌(Ca9-22、Cal-27細胞株)、血癌(K562、Molt 4細胞株)、腦癌(GBM8401、U87MG細胞株)、胃癌(KATO III、SNU-1細胞株)、大腸癌(DLD-1細胞株)、前列腺癌(LN-cap、PC-3細胞株)進行優格飲品11至14經分離方法3所獲得16個萃取物的抑制癌細胞生長活性測試。實驗方法為細胞存活率分析(MTT assay),將各種癌細胞植入96孔盤,每孔細胞密度為7×103cells/100μL,再加入不同濃度(在100μg/mL之內)的樣品(以DMSO作為控制組),置於37℃、5% CO2細胞培養箱靜置72小時。再加入50μL MTT,培養1小時。以2000rpm離心3分鐘,去除上清液再加入200μL DMSO,置於震盪器上搖晃至紫色結晶完全溶解,讀取570mm及620mm的吸光值。結果呈現為不同樣品以100μg/mL濃度內處理後,最佳抑制癌細胞生長百分比。口腔癌的人體臨床治療以手術、放射治療(電療)為主,本實驗中的16個萃取物未顯示抑制口腔癌細胞生長的效果。其他癌症細胞的實驗結果如表18及第20圖至第24圖所示。 For the related organs of the symbiotic bacteria-gut-brain axis, the active metabolites will be ingested from the oral cavity and will pass through the digestive tract, blood, circulatory system, and urinary system (excretion system). Oral cancer (Ca9-22, Cal- 27 cell line), blood cancer (K562, Molt 4 cell line), brain cancer (GBM8401, U87MG cell line), gastric cancer (KATO III, SNU-1 cell line), colorectal cancer (DLD-1 cell line), prostate cancer ( LN-cap, PC-3 cell strains) were tested for the cancer cell growth inhibitory activity of 16 extracts from Yogurt Drink 11 to 14 obtained by separation method 3. The experimental method is cell viability analysis (MTT assay), in which various cancer cells are implanted into 96-well plates with a cell density of 7×10 3 cells/100μL per well, and then samples of different concentrations (within 100μg/mL) are added ( Take DMSO as the control group) and place them in a 37°C, 5% CO 2 cell incubator for 72 hours. Then add 50μL MTT and incubate for 1 hour. Centrifuge at 2000 rpm for 3 minutes, remove the supernatant and add 200 μL of DMSO, place on a shaker and shake until the purple crystals are completely dissolved, and read the absorbance values at 570 mm and 620 mm. Results are presented as the different samples processed in the 100 μ g / mL concentration, the best percentage of growth inhibition of cancer cells. The human clinical treatment of oral cancer is mainly surgery and radiotherapy (electrotherapy). The 16 extracts in this experiment did not show the effect of inhibiting the growth of oral cancer cells. The experimental results of other cancer cells are shown in Table 18 and Figures 20 to 24.

Figure 108125099-A0101-12-0038-121
Figure 108125099-A0101-12-0038-121
Figure 108125099-A0101-12-0039-122
Figure 108125099-A0101-12-0039-122

1.抑制血癌細胞(K562、Molt 4細胞株)的生長活性:1. Inhibit the growth activity of blood cancer cells (K562, Molt 4 cell lines):

如第20圖所示,在抑制血癌細胞K562生長方面,優格飲品11的萃取物中,11-A的抑制活性最佳,11-W最弱;優格飲品12的萃取物中,12-A的抑制活性最佳,12-W最弱;優格飲品13的萃取物中,13-W的抑制活性最佳,13-H最弱;優格飲品14的萃取物中,14-A的抑制活性最佳,14-W最弱。綜合16個萃取物中,12-A的抑制癌細胞生長活性最佳。如第20圖所示,在抑制血癌細胞Molt 4生長方面,優格飲品11的萃取物中,11-H的抑制活性最佳,11-E、11-W皆無抑制活性;優格飲品12的萃取物中,12-A的抑制活性最佳,12-H、12-W皆無抑制活性;優格飲品13的萃取物中,13-A的抑制活性最佳,13-E最弱;優格飲品14的萃取物中,14-E的抑制活性最佳,14-A、14-W皆無抑制活性。綜合16個萃取物中,14-E的抑制活性最佳。 As shown in Figure 20, in terms of inhibiting the growth of blood cancer cells K562, among the extracts of Yogurt Drink 11, 11-A has the best inhibitory activity and 11-W is the weakest; among the extracts of Yogurt Drink 12, 12- A has the best inhibitory activity and 12-W is the weakest; among the extracts of yogurt drink 13, 13-W has the best inhibitory activity and 13-H is the weakest; among the extracts of yogurt drink 14, 14-A The inhibitory activity is the best, and 14-W is the weakest. Among the 16 extracts, 12-A has the best cancer cell growth inhibitory activity. As shown in Figure 20, in terms of inhibiting the growth of blood cancer cells Molt 4, among the extracts of Yogurt Drink 11, 11-H has the best inhibitory activity, and 11-E and 11-W have no inhibitory activity; Yogurt Drink 12 has the best inhibitory activity. Among the extracts, 12-A has the best inhibitory activity, 12-H and 12-W have no inhibitory activity; among the extracts of Yogurt Drink 13, 13-A has the best inhibitory activity and 13-E is the weakest; Yogurt Among the extracts of Drink 14, 14-E has the best inhibitory activity, and both 14-A and 14-W have no inhibitory activity. Among the 16 extracts, 14-E has the best inhibitory activity.

2.抑制腦癌細胞(GBM8401、U87MG細胞株)生長活性:2. Inhibit the growth activity of brain cancer cells (GBM8401, U87MG cell line):

如第21圖所示,在抑制腦癌細胞GBM8401生長方面,優格飲品11的萃取物中,11-A的抑制活性最佳,11-E最弱;優格飲品12的萃取物中,12-A的抑制活性最佳,12-W最弱;優格飲品13的萃取物中,13-H的抑制活性最佳,13-W最弱;優格飲品14的萃取物中,14-A的抑制活性最佳,14-H最弱。綜合16個萃取物中,11-A的抑制活性最佳。如第21圖所示,在抑制細胞U87MG生長方面,優格飲品11的萃取物中,11-A的抑制活性最佳,11-W最弱;優格飲品12的萃取物中,12-H的抑制活性最佳,12-W最弱;優格飲品13的萃取物中,13-H的抑制活性最佳,13-E、13-W皆無抑制活性;優格飲品14的萃取物中,14-W的抑制活性最佳,14-E 最弱。綜合16個萃取物中,14-W的抑制活性最佳。 As shown in Figure 21, in terms of inhibiting the growth of brain cancer cells GBM8401, among the extracts of Yogurt Drink 11, 11-A has the best inhibitory activity and 11-E is the weakest. Among the extracts of Yogurt Drink 12, 12 -A has the best inhibitory activity and 12-W is the weakest; among the extracts of yogurt drink 13, 13-H has the best inhibitory activity and 13-W is the weakest; among the extracts of yogurt drink 14, 14-A The inhibitory activity is the best, and 14-H is the weakest. Among the 16 extracts, 11-A has the best inhibitory activity. As shown in Figure 21, in terms of inhibiting the growth of U87MG cells, among the extracts of Yogurt Drink 11, 11-A has the best inhibitory activity and 11-W is the weakest; among the extracts of Yogurt Drink 12, 12-H The inhibitory activity of yogurt is the best, and 12-W is the weakest. Among the extracts of yogurt drink 13, 13-H has the best inhibitory activity. Neither 13-E nor 13-W has inhibitory activity; in the extract of yogurt drink 14, there is no inhibitory activity. 14-W has the best inhibitory activity, 14-E The weakest. Among the 16 extracts, 14-W has the best inhibitory activity.

3.抑制胃癌細胞(KATO III、SNU-1細胞株)生長活性:3. Inhibit the growth activity of gastric cancer cells (KATO III, SNU-1 cell lines):

如第22圖所示,在抑制胃癌細胞KATO III生長方面,優格飲品11的萃取物中,11-H的抑制活性最佳,11-W最弱;優格飲品12的萃取物中,12-E的抑制活性最佳,12-H、12-W皆無抑制活性;優格飲品13的萃取物中,只有13-E具有抑制活性;優格飲品14的萃取物中,14-W的抑制活性最佳,14-A最弱。綜合16個萃取物中,14-W的抑制活性最佳。如第22圖所示,在抑制胃癌細胞SNU-1生長方面,優格飲品11的萃取物中,11-H的抑制活性最佳,11-A最弱;優格飲品12的萃取物中,12-E的抑制活性最佳,12-W最弱;優格飲品13的萃取物中,13-H的抑制活性最佳,13-A最弱;優格飲品14的萃取物中,14-A的抑制活性最佳,14-E最弱。綜合16個萃取物中,12-E的抑制活性最佳。 As shown in Figure 22, in terms of inhibiting the growth of gastric cancer cells KATO III, among the extracts of Yogurt Drink 11, 11-H has the best inhibitory activity and 11-W is the weakest. Among the extracts of Yogurt Drink 12, 12 -E has the best inhibitory activity, 12-H and 12-W have no inhibitory activity; in the extract of Yogurt Drink 13, only 13-E has inhibitory activity; in the extract of Yogurt Drink 14, 14-W is inhibited The activity is the best, and 14-A is the weakest. Among the 16 extracts, 14-W has the best inhibitory activity. As shown in Figure 22, in terms of inhibiting the growth of gastric cancer cells SNU-1, among the extracts of Yogurt Drink 11, 11-H has the best inhibitory activity and 11-A is the weakest. Among the extracts of Yogurt Drink 12, The inhibitory activity of 12-E is the best, and 12-W is the weakest. Among the extracts of Yogurt Drink 13, 13-H has the best inhibitory activity and 13-A is the weakest. Among the extracts of Yogurt Drink 14, 14- A has the best inhibitory activity and 14-E has the weakest. Among the 16 extracts, 12-E has the best inhibitory activity.

4.抑制大腸癌細胞(DLD-1細胞株)生長活性:4. Inhibit the growth activity of colorectal cancer cells (DLD-1 cell line):

如第23圖所示,在抑制大腸癌細胞DLD-1生長方面,優格飲品11的萃取物中,11-H的抑制活性最佳,11-W最弱;優格飲品12的萃取物中,12-H的抑制活性最佳,12-E最弱;優格飲品13的萃取物中,13-H的抑制活性最佳,13-W最弱;優格飲品14的萃取物中,14-A的抑制活性最佳,14-E最弱。綜合16個萃取物中,11-A的抑制活性最佳。 As shown in Figure 23, in terms of inhibiting the growth of colorectal cancer cells DLD-1, among the extracts of Yogurt Drink 11, 11-H has the best inhibitory activity and 11-W is the weakest; among the extracts of Yogurt Drink 12 , 12-H has the best inhibitory activity and 12-E is the weakest; among the extracts of yogurt drink 13, 13-H has the best inhibitory activity and 13-W is the weakest; among the extracts of yogurt drink 14, 14 -A has the best inhibitory activity and 14-E has the weakest. Among the 16 extracts, 11-A has the best inhibitory activity.

5.抑制前列腺癌細胞(LN-cap、PC-3細胞株)生長活性:5. Inhibit the growth activity of prostate cancer cells (LN-cap, PC-3 cell lines):

如第24圖所示,在抑制前列腺癌細胞LN-cap生長方面,優格飲品11的萃取物中,11-A的抑制活性最佳,11-E最弱;優格飲品12的萃取物中,12-H的抑制活性最佳,12-E最弱;優格飲品13的萃取物中,13-A的抑制活性最佳,13-H、13-E皆無抑制活性;優格飲品14的萃取物中,14-W的抑制活性最佳,14-H最弱。綜合16個萃取物中,11-A的抑制活性最佳。如第24圖所示,在抑制前列腺癌細胞PC-3生長方面,優格飲品11的萃取物中,11-E的抑制活性最佳,11-H最弱;優格飲品12的萃取 物中,12-H的抑制活性最佳,12-W最弱;優格飲品13的萃取物中,13-E的抑制活性最佳,13-H、13-W皆無抑制活性;優格飲品14的萃取物中,14-E的抑制活性最佳,14-A最弱。綜合16個萃取物中,13-E的抑制活性最佳。 As shown in Figure 24, in terms of inhibiting the growth of prostate cancer cells LN-cap, among the extracts of Yogurt Drink 11, 11-A has the best inhibitory activity and 11-E is the weakest; among the extracts of Yogurt Drink 12 , 12-H has the best inhibitory activity, and 12-E is the weakest; among the extracts of yogurt drink 13, 13-A has the best inhibitory activity, 13-H and 13-E have no inhibitory activity; yogurt drink 14 has the best inhibitory activity. Among the extracts, 14-W has the best inhibitory activity and 14-H has the weakest. Among the 16 extracts, 11-A has the best inhibitory activity. As shown in Figure 24, in terms of inhibiting the growth of prostate cancer cell PC-3, among the extracts of Yogurt Drink 11, 11-E has the best inhibitory activity and 11-H is the weakest; Yogurt Drink 12 is the extract Among them, 12-H has the best inhibitory activity, and 12-W is the weakest; among the extracts of Yogurt Drink 13, 13-E has the best inhibitory activity, and both 13-H and 13-W have no inhibitory activity; Yogurt Drinks Among the 14 extracts, 14-E has the best inhibitory activity and 14-A has the weakest. Among the 16 extracts, 13-E has the best inhibitory activity.

實驗9、優格飲品生產系統:Experiment 9. Yogurt Beverage Production System:

過去的液態優格飲品在生產上分為二種形式:家庭式自製小量生產以及噸級工廠大量生產。家庭式小量生產有品質不穩定、需後續調製、操作不便的問題。噸級工廠大量生產會面臨從消費者購買及飲用飲品時已經過2至3天或以上,新鮮發酵的優格飲品無法被當日飲用,且常有無法在保存期限內喝完、或保存不當變質的問題。因此,本發明提供一種液態優格飲品的生產系統,能同時解決上述家庭式自製小量生產、噸級工廠大量生產優格飲品的問題,以單一發酵機就能生產公斤級液態優格飲品,能在現場以透明化製程發酵製作,於18小時完成,讓消費者每天飲用的優格飲品皆為當日新鮮發酵現做,終端產品以手搖飲方式出餐。 In the past, liquid yogurt beverages were produced in two forms: home-made small-scale production and mass production in ton-level factories. Household small-scale production has the problems of unstable quality, need for subsequent modulation, and inconvenient operation. Mass production in a ton-level factory will face 2 to 3 days or more from the time consumers buy and drink the drink, the freshly fermented yogurt drink cannot be consumed on the same day, and often it cannot be consumed within the shelf life, or it is improperly preserved. The problem. Therefore, the present invention provides a liquid yogurt beverage production system, which can simultaneously solve the above-mentioned home-made small-volume production and large-scale production of yogurt beverages in ton-level factories. A single fermentation machine can produce kilogram-level liquid yogurt beverages. It can be fermented on-site with a transparent process and completed in 18 hours. The yogurt drinks that consumers drink every day are freshly fermented that day, and the end products are served by hand shake.

如第25圖所示的製程及第26圖所示的發酵機100的結構,本發明液態優格飲品生產系統的依序包括:高壓清洗、高溫滅菌、製奶乳化、二次滅菌、接菌發酵、成品抽樣、成品收槽、降溫冷藏、均質調製、加入配料、充填包裝、產品出餐。 As shown in the manufacturing process shown in Figure 25 and the structure of the fermentation machine 100 shown in Figure 26, the liquid yogurt beverage production system of the present invention sequentially includes: high pressure cleaning, high temperature sterilization, milk emulsification, secondary sterilization, inoculation Fermentation, finished product sampling, finished product collection, cooling and refrigeration, homogenizing preparation, adding ingredients, filling and packaging, product serving.

用於製備優格飲品的發酵機100包括:槽體101、與槽體101組裝的密封頂蓋105、設置於密封頂蓋105上的投料口M、設置於槽體101外的電機控制器108、耦接於電機控制器108的攪拌馬達110、設置於槽體101空間內且連接於攪拌馬達110的攪拌臂104、設置於槽體101外且耦接於電機控制器108的電阻增溫器103。其中,密封頂蓋105與槽體101所圍設的空間為密閉狀態;水、奶粉以及菌粉經由投料口M被送入該空間內;電阻增溫器103用以消毒水及奶粉,並使菌粉在水以及奶粉所形成的混合物中於37℃至43℃之間受攪拌臂104攪拌而製備成優格飲品。 The fermentation machine 100 for preparing yogurt drinks includes: a tank body 101, a sealed top cover 105 assembled with the tank body 101, a feeding port M provided on the sealed top cover 105, and a motor controller 108 provided outside the tank body 101 , The stirring motor 110 coupled to the motor controller 108, the stirring arm 104 arranged in the space of the tank 101 and connected to the stirring motor 110, and the resistance warmer arranged outside the tank 101 and coupled to the motor controller 108 103. Among them, the space enclosed by the sealing top cover 105 and the tank body 101 is in a closed state; water, milk powder, and bacterial powder are fed into the space through the feeding port M; the resistance warmer 103 is used to sterilize the water and milk powder, and make The bacterial powder is stirred by the stirring arm 104 in the mixture formed by water and milk powder at 37°C to 43°C to prepare a yogurt drink.

進一步而言,發酵機100還包括設置於槽體101底部、而供該優格飲品或廢液(或廢水)排出的出料口N4。替代地,發酵機100還包括設置於槽體101外且與電阻增溫器103連接的控溫夾層102,該控溫夾層102用以受電阻增溫器103的控制而調整或維持空間內的溫度。替代地,密封頂蓋105上還包括清洗口106,發酵機100還包括設置於槽體101側邊的導熱流入口N5以及底部的導熱流出口N6。替代地,發酵機100還包括耦接於電機控制器108的感溫探測器107,且感溫探測器107感測的溫度顯示於電機控制器108的螢幕109上。替代地,密封頂蓋105上的觀察窗S1可供使用者目視槽體101內的狀況。 Furthermore, the fermentation machine 100 further includes a discharge port N4 arranged at the bottom of the tank body 101 for discharging the yogurt drink or waste liquid (or waste water). Alternatively, the fermentation machine 100 further includes a temperature control interlayer 102 arranged outside the tank body 101 and connected to the resistance warmer 103. The temperature control interlayer 102 is used to adjust or maintain the temperature in the space under the control of the resistance warmer 103. temperature. Alternatively, the sealing top cover 105 further includes a cleaning port 106, and the fermentation machine 100 further includes a heat conduction inflow port N5 provided at the side of the tank body 101 and a heat conduction outflow port N6 at the bottom. Alternatively, the fermentation machine 100 further includes a temperature sensor 107 coupled to the motor controller 108, and the temperature sensed by the temperature sensor 107 is displayed on the screen 109 of the motor controller 108. Alternatively, the observation window S1 on the sealing top cover 105 allows the user to visually observe the condition in the tank body 101.

第25圖的製程如下所述: The manufacturing process in Figure 25 is as follows:

(1)高壓清洗、高溫滅菌:打開投料口M→使用高壓噴槍對槽體101內壁進行清理→由觀察窗S1確認水位高度至適當位置→開啟出料口N4排放→槽體101再次加滿水→感溫探測器107偵測到的溫度顯示於電機控制器108的螢幕109→顯示加熱至72℃以上→達到滅菌溫度後→靜置30分鐘→開啟出料口N4排放至廢水槽(未示出)。 (1) High-pressure cleaning and high-temperature sterilization: open the feeding port M → use a high-pressure spray gun to clean the inner wall of the tank 101 → confirm the water level to the proper position through the observation window S1 → open the discharge port N4 to discharge → the tank 101 is filled up again Water → The temperature detected by the temperature sensor 107 is displayed on the screen 109 of the motor controller 108 → It shows that it is heated to above 72°C → After reaching the sterilization temperature → Let it stand for 30 minutes → Open the discharge port N4 and discharge to the waste water tank (not show).

(2)製奶乳化:打開投料口M→注入潔淨水→投入奶粉→開啟攪拌馬達110→進行乳化→關閉投料口M→由觀察窗S1確認乳化情況。 (2) Milk emulsification: open the feeding port M → inject clean water → put in milk powder → turn on the stirring motor 110 → perform emulsification → close the feeding port M → confirm the emulsification status through the observation window S1.

(3)二次滅菌:開啟加溫→觀察螢幕109顯示加熱至72℃以上→達到滅菌溫度後→關閉加溫→靜置30分鐘。 (3) Secondary sterilization: turn on heating→observe that the screen 109 shows heating to above 72°C→after reaching the sterilization temperature→turn off heating→stand for 30 minutes.

(4)接菌發酵:將冷卻水由導熱流入口N5注入→開啟循環泵(未示出)→以冷卻水進行熱交換控溫→觀察螢幕109顯示逐步降溫至43℃→關閉冷卻水源與循環泵→投料口M以75%酒精消毒→迅速打開投料口M投菌並且關閉旋緊→開啟攪拌馬達110使攪拌臂104運轉攪拌20分鐘→關閉攪拌馬達110→靜置發酵。 (4) Inoculation and fermentation: inject cooling water from the heat conduction inlet N5 → turn on the circulating pump (not shown) → use cooling water for heat exchange and temperature control → observe the screen 109 shows that the temperature is gradually reduced to 43°C → turn off the cooling water source and circulation Pump → Sterilize the feeding port M with 75% alcohol → quickly open the feeding port M to inject bacteria and close the screw tightly → turn on the stirring motor 110 to make the stirring arm 104 operate and stir for 20 minutes → turn off the stirring motor 110 → stand for fermentation.

(5)成品抽樣:以純淨水噴灑出料口N4再噴灑75%酒精消毒→取出300毫升樣品→進行黏度、pH值檢測→黏度、pH值達收槽標準→進行收槽。 (5) Finished product sampling: spray the discharge port N4 with pure water and then spray 75% alcohol for disinfection → take out 300 ml sample → check the viscosity and pH value → the viscosity and pH value reach the sink standard → proceed to the sink.

(6)成品收槽:以純淨水噴灑出料口N4→噴灑75%酒精消毒→使用304食品級不銹鋼容器分批盛接。 (6) Finished product receiving tank: spray the discharge port N4 with pure water → spray 75% alcohol for disinfection → use 304 food grade stainless steel containers to receive in batches.

(7)降溫冷藏:優格飲品放量製備→4℃冷藏。 (7) Cooling and refrigeration: preparing yogurt drinks in large quantities → refrigerating at 4°C.

(8)均質調製、加入配料:取優格飲品→加入冰塊→使用均質機進行均質→固態配料或固態水果配料進行調製。 (8) Homogeneous preparation and addition of ingredients: take yogurt drink → add ice cubes → homogenize with a homogenizer → prepare solid ingredients or solid fruit ingredients for preparation.

(9)充填包裝、產品出餐:最後再次檢查飲品或配料是否有滲出→完成。 (9) Filling the packaging and serving the product: Finally, check again whether the drink or ingredients ooze out → complete.

本發明實屬難能的創新發明,深具產業價值,援依法提出申請。此外,本發明可以由所屬技術領域中具有通常知識者做任何修改,但不脫離如所附申請專利範圍所要保護的範圍。 The present invention is really a difficult innovative invention and has deep industrial value, and it is necessary to file an application in accordance with the law. In addition, the present invention can be modified by persons with ordinary knowledge in the relevant technical field, but does not deviate from the scope of protection as claimed in the attached patent scope.

<110> 宇洋生物醫學股份有限公司 <110> Yuyang Biomedical Co., Ltd.

<120> 具抗氧化與抑制消化道癌細胞生長的優格生技飲品及其製備方法 <120> Yogurt biotechnology drink with anti-oxidation and inhibiting the growth of digestive tract cancer cells and its preparation method

<160> 2 <160> 2

<210> 1 <210> 1

<211> 1478 <211> 1478

<212> rDNA <212> rDNA

<213> 發酵乳桿菌(Lactobacillus fermentum) <213> Lactobacillus fermentum

<220> <220>

<223> 菌種代號UY-58的16S rDNA <223> 16S rDNA of strain code UY-58

<400> 1

Figure 108125099-A0101-12-0045-48
Figure 108125099-A0101-12-0046-49
<400> 1
Figure 108125099-A0101-12-0045-48
Figure 108125099-A0101-12-0046-49

<210> 2 <210> 2

<211> 1515 <211> 1515

<212> rDNA <212> rDNA

<213> 瑞士乳桿菌(Lactobacillus helveticus) <213> Lactobacillus helveticus

<220> <220>

<223> 菌種代號UY-76的16S rDNA <223> 16S rDNA of strain code UY-76

<400> 2

Figure 108125099-A0101-12-0046-50
<400> 2
Figure 108125099-A0101-12-0046-50

Claims (13)

一種優格飲品,包括:一動物乳汁製品,包括水及動物乳汁;複數菌粉,與該動物乳汁製品相混合,其中該複數菌粉來自於對應的複數種菌株,該複數種菌株包括:長雙岐桿菌(Bifidobacterium longum)、嗜酸乳桿菌(Lactobacillus acidophilus)、副乾酪乳桿菌(Lactobacillus paracasei)以及鼠李糖桿菌(Lactobacillus rhamnosus)。 A yogurt drink includes: an animal milk product, including water and animal milk; a plurality of bacterial powders mixed with the animal milk product, wherein the plural bacterial powders are derived from corresponding plural strains, and the plural strains include: long Bifidobacterium longum , Lactobacillus acidophilus , Lactobacillus paracasei , and Lactobacillus rhamnosus . 如申請專利範圍第1項所述的優格飲品,其中該複數種菌株更包括:比菲德氏菌(Bifidobacterium bifidum)、短雙岐桿菌(Bifidobacterium breve)、雷特氏雙岐桿菌(Bifidobacterium lactis)、乾酪乳桿菌(Lactobacillus casei)、保加利亞乳桿菌(Lactobacillus delbrueckii subsp.bulgaricus)、瑞士乳桿菌(Lactobacillus helveticus)、植物乳桿菌(Lactobacillus plantarum)以及嗜熱鏈球菌(Streptococcus thermophilus)。 The yogurt drink described in item 1 of the scope of patent application, wherein the plurality of strains further include: Bifidobacterium bifidum , Bifidobacterium breve , Bifidobacterium lactis ), Lactobacillus casei (Lactobacillus casei), Lactobacillus delbrueckii subsp. bulgaricus , Lactobacillus helveticus , Lactobacillus plantarum , and Streptococcus thermophilus . 如申請專利範圍第1項所述的優格飲品,其中該複數種菌株更包括:比菲德氏菌(Bifidobacterium bifidum)、雷特氏雙岐桿菌(Bifidobacterium lactis)、糞腸球菌(Enterococcus faecium)、乾酪乳桿菌(Lactobacillus casei)、發酵乳桿菌(Lactobacillus fermentum)、植物乳桿菌(Lactobacillus plantarum)以及嗜熱鏈球菌(Streptococcus thermophilus)。 The yogurt drink described in item 1 of the scope of patent application, wherein the plurality of strains further include: Bifidobacterium bifidum , Bifidobacterium lactis , Enterococcus faecium , Lactobacillus casei , Lactobacillus fermentum , Lactobacillus plantarum , and Streptococcus thermophilus . 如申請專利範圍第1項所述的優格飲品,其中該複數種菌株更包括:發酵乳桿菌(Lactobacillus fermentum)、瑞士乳桿菌(Lactobacillus helveticus)、唾液乳酸桿菌(Lactobacillus salivarius)以及嗜熱鏈球菌(Streptococcus thermophilus)。 The yogurt drink according to item 1 of the patent application, wherein the plurality of strains further include: Lactobacillus fermentum , Lactobacillus helveticus , Lactobacillus salivarius , and Streptococcus thermophilus ( Streptococcus thermophilus ). 如申請專利範圍第1-4項中任一項所述的優格飲品,其中各該複數種菌株的菌粉重量均相同。 The yogurt drink according to any one of items 1 to 4 in the scope of the patent application, wherein the weight of the bacterial powder of each of the plurality of strains is the same. 如申請專利範圍第1-4項中任一項所述的優格飲品,其中該優格飲品還包括一醬汁配料,該醬汁配料選自由黑糖、蜂蜜及其組合所組成的群組其 中之一。 The yogurt drink according to any one of items 1 to 4 in the scope of the patent application, wherein the yogurt drink further includes a sauce ingredient selected from the group consisting of brown sugar, honey and combinations thereof One of them. 如申請專利範圍第1-4項中任一項所述的優格飲品,其中該優格飲品還包括一固態配料,該固態配料選自由珍珠、椰果、咖啡凍、芋圓、布丁、紅豆、紫米、燕麥及其組合所組成的群組其中之一。 The yogurt drink according to any one of items 1 to 4 in the scope of the patent application, wherein the yogurt drink further includes a solid ingredient selected from pearls, coconuts, coffee jelly, taro balls, pudding, and red beans One of the group consisting of, purple rice, oats and their combinations. 如申請專利範圍第1-4項中任一項所述的優格飲品,其中該優格飲品還包括一固態水果配料,該固態水果配料選自由芒果、草莓、火龍果、百香果、酪梨、香蕉、奇異果、柳橙、葡萄柚及其組合所組成的群組其中之一。 The yogurt drink according to any one of items 1 to 4 in the scope of the patent application, wherein the yogurt drink further includes a solid fruit ingredient selected from the group consisting of mango, strawberry, dragon fruit, passion fruit, and avocado , Banana, kiwi, orange, grapefruit, and combinations thereof. 如申請專利範圍第1-4項中任一項所述的優格飲品,其中該複數種菌株在該動物乳汁製品中,以37℃至43℃發酵8小時至12小時。 The yogurt drink according to any one of items 1 to 4 in the scope of the patent application, wherein the plurality of strains are fermented in the animal milk product at 37°C to 43°C for 8 hours to 12 hours. 一種申請專利範圍第1至4項中任一項之優格飲品的分離方法,包括:冷凍乾燥該優格飲品,獲得一粉狀產物;以正己烷萃取該粉狀產物,獲得一正己烷萃取物及一第一殘留物,其中該正己烷萃取物的主量成分為具有雙鍵及氫氧基的短鏈脂肪酸;以乙酸乙酯萃取該第一殘留物,獲得一乙酸乙酯萃取物及一第二殘留物,其中該乙酸乙酯萃取物的主量成分為糖脂;以乙醇萃取該第二殘留物,獲得一乙醇萃取物及一第三殘留物,其中該乙醇萃取物的主量成分包括雙醣及寡醣;以及以水萃取該第三殘留物,獲得一水萃取物及一第四殘留物,其中該水萃取物的主量成分包括多醣、醣蛋白以及蛋白質。 A method for separating yogurt drink according to any one of items 1 to 4 in the scope of patent application, comprising: freeze-drying the yogurt drink to obtain a powdered product; extracting the powdered product with n-hexane to obtain a n-hexane extraction And a first residue, wherein the main components of the n-hexane extract are short-chain fatty acids with double bonds and hydroxyl groups; the first residue is extracted with ethyl acetate to obtain an ethyl acetate extract and A second residue, wherein the main component of the ethyl acetate extract is glycolipid; the second residue is extracted with ethanol to obtain an ethanol extract and a third residue, wherein the main component of the ethanol extract is The components include disaccharides and oligosaccharides; and the third residue is extracted with water to obtain a water extract and a fourth residue, wherein the main components of the water extract include polysaccharides, glycoproteins and proteins. 如申請專利範圍第10項所述的分離方法,其中該正己烷萃取物及該乙酸乙酯萃取物以正相薄層層析法進行成分分析,該正相薄層層析法的溶媒系統為甲苯:乙酸乙酯:甲酸=5:4:1(v/v/v)。 The separation method described in item 10 of the scope of patent application, wherein the n-hexane extract and the ethyl acetate extract are subjected to component analysis by normal phase thin layer chromatography, and the solvent system of the normal phase thin layer chromatography is Toluene: ethyl acetate: formic acid = 5: 4: 1 (v/v/v). 如申請專利範圍第10項所述的分離方法,其中該乙醇萃取物及該水萃取物以逆相高效液相層析法進行成分分析。 The separation method as described in item 10 of the scope of patent application, wherein the ethanol extract and the water extract are subjected to component analysis by reverse phase high performance liquid chromatography. 一種將申請專利範圍第1至4項中任一項之優格飲品用於抑制癌細胞生長 的用途,其中該癌細胞選自由血癌細胞、腦癌細胞、胃癌細胞、大腸癌細胞及其組合所組成的群組其中之一。 A yogurt drink that uses any one of items 1 to 4 in the scope of patent application to inhibit the growth of cancer cells Wherein, the cancer cells are selected from one of the group consisting of blood cancer cells, brain cancer cells, gastric cancer cells, colorectal cancer cells and combinations thereof.
TW108125099A 2019-07-12 2019-07-12 Yogurt bio beverage for anti-oxidation and anti-proliferation against human digestive tract cancer cell lines, and its preparation method TWI835820B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
TW108125099A TWI835820B (en) 2019-07-12 2019-07-12 Yogurt bio beverage for anti-oxidation and anti-proliferation against human digestive tract cancer cell lines, and its preparation method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TW108125099A TWI835820B (en) 2019-07-12 2019-07-12 Yogurt bio beverage for anti-oxidation and anti-proliferation against human digestive tract cancer cell lines, and its preparation method

Publications (2)

Publication Number Publication Date
TW202102121A true TW202102121A (en) 2021-01-16
TWI835820B TWI835820B (en) 2024-03-21

Family

ID=75234894

Family Applications (1)

Application Number Title Priority Date Filing Date
TW108125099A TWI835820B (en) 2019-07-12 2019-07-12 Yogurt bio beverage for anti-oxidation and anti-proliferation against human digestive tract cancer cell lines, and its preparation method

Country Status (1)

Country Link
TW (1) TWI835820B (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW201815290A (en) * 2016-10-17 2018-05-01 漢豐流通股份有限公司 Yogurt fermentation bacteria, whole bacteria yoghurt, and manufacturing method of whole bacteria yogurt enabling bacteria to grow in a balanced manner, complement one another, and prevent individual colonies from being dissolved and destroyed by digestive fluids when passing through the digestive tract

Also Published As

Publication number Publication date
TWI835820B (en) 2024-03-21

Similar Documents

Publication Publication Date Title
Hussein et al. Impact of chickpea as prebiotic, antioxidant and thickener agent of stirred bio-yoghurt
Amorim et al. Probiotic potential of yeasts isolated from pineapple and their use in the elaboration of potentially functional fermented beverages
Servili et al. Functional milk beverage fortified with phenolic compounds extracted from olive vegetation water, and fermented with functional lactic acid bacteria
Coman et al. Functional foods as carriers for SYNBIO®, a probiotic bacteria combination
El-Sayed et al. Production of UF-soft cheese using probiotic bacteria and Aloe vera pulp as a good source of nutrients
KR101239806B1 (en) The new Lactobacillus plantarum HY7712 stimulate immunity
Farag et al. Rediscovering acidophilus milk, its quality characteristics, manufacturing methods, flavor chemistry and nutritional value
Mazzaglia et al. The influence of almond flour, inulin and whey protein on the sensory and microbiological quality of goat milk yogurt
Gomes et al. Fruit-based non-dairy beverage: A new approach for probiotics
Ghafari et al. Microbial viability, physico-chemical properties and sensory evaluation of pineapple juice enriched with Lactobacillus casei, Lactobacillus rhamnosus and inulin during refrigerated storage
CN109965269A (en) Food compositions and its application
CN104771416B (en) Lactobacillus reuteri GMNL-263 composition for controlling body weight and application thereof
Yu et al. Peanut sprout yogurt: Increased antioxidant activity and nutritional content and sensory evaluation by fuzzy mathematics
JP4119656B2 (en) Antioxidant
CN212382028U (en) Fermentation machine of sour milk raw technology drink
TW202102120A (en) Semisolid yogurt for anti-oxidation and anti-proliferation against human prostate cancer cell lines, and its preparation method
CN112205473A (en) Yoghourt biotechnological beverage with functions of resisting oxidation and inhibiting growth of digestive tract cancer cells and preparation method thereof
TWI835820B (en) Yogurt bio beverage for anti-oxidation and anti-proliferation against human digestive tract cancer cell lines, and its preparation method
Othman et al. Effects of jackfruit puree supplementation on lactic acid bacteria (Lactobacillus acidophilus FTDC 1295) in terms of viability and chemical compositions of dadih.
TWM587175U (en) Fermenter of the yogurt bio beverage
Asiri et al. Effect of functional ingredients on viability of Lactobacillus acidophilus bacteria in nondairy probiotic products
Savitha et al. Role of Probiotic Microbes Exerting Nutritional Properties
Swe et al. Use of pigmented rice as carrier and stingless bee honey as prebiotic to formulate novel synbiotic products mixed with three strains of probiotic bacteria
TWI568441B (en) A lactobacillus reuteri gmnl-263 composition for controlling body weight and its use thereof
Mpopo et al. Formulation of Functional Yogurt by Cofermentation of Milk and Papaya Fruit